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Materials and Methods – Experiments 
Cell culture and reagents 
NIH3T3 cells were obtained from ATCC (CRL-1658). All the subsequent cell lines were derived from the parental 
NIH3T3 cells. All cells were cultured in DMEM supplemented with 10% Calf Serum (ThermoFisher/Hyclone, 
#SH30087), 1x Pen/Strep/Glutamine (Gibco, #10378-016), and 1 mM Sodium Pyruvate (Gibco, #11360070). For 
regular cell line maintenance, cells were passaged every 3 days at 1:10. For all the assays, receiver cells were 
grown into 100% confluency before being stimulated with ligands or spatially patterned to form gradients. To 
reduce the background fluorescence, colorless FluoroBrite DMEM (ThermoFisher, #A18967) with 10% Calf 
Serum was used for all the time-lapse image acquisition.  
 
Engineering stable cell lines 
All transgenes were cloned into the PiggyBac transposon system (System Biosciences), which allows more 
efficient genomic integration of multiple vectors simultaneously (Table S3). All constructs were transfected into 
cells facilitated by PiggyBac transposase and Lipofectamine LTX (ThermoFisher, #15338100). Cells stably 
integrated with the corresponding constructs were selected and enriched with the following antibiotics: 
Hygromycin (InvivoGen, #ant-hg, 300 µg/ml), Blasticidin (InvivoGen, #ant-bl, 10 µg/ml), Puromycin (Gibco, 
#A11138-03, 3 µg/ml), and Geneticin (Gibco, #10131-35, 600 µg/ml). In cases where two different constructs 
were co-transfected simultaneously, a sequential antibiotic selection procedure (alternating between the two 
antibiotics every 2-3 days) was used to enrich for double-positive polyclonal population. Then clonal population 
was selected and characterized upon single-cell limiting dilution. The details about the cell lines are described 
below:  
• SHH senders: To control SHH expression in an inducible fashion, a mutant estrogen receptor was fused 
to GAL4 (ERT2-GAL4), which enables the activation of the UAS promoter by adding (Z)4-
Hydroxytamoxifen (4-OHT, Sigma, #H7904) (29).  
• Wild-type receivers: To report the intracellular signaling activity, a transcription-based reporter was 
created by using 8 tandem copies of GLI binding sequence (GBS)(10) and a minimal CMV promoter to 
control the expression of H2B-Citrine (Fig. S1).  
• Ptch1-/- receivers (Fig. S3): In the wild-type receiver background, both alleles of the endogenous Ptch1 
were knocked out using CRISPR (Table S4, Fig. S3). Multiple guide RNA sequences were tested, and the 
one targeting the intron-exon junction produced the highest knockout efficiency.  
• Open loop receivers (Figs. 2A, S3): To create feedback-free cells, ectopic expression of PTCH1 was 
restored in Ptch1-/- receivers using Tet-3G inducible system (Life Technologies) (30, 31). Tet-3G is 
constitutively expressed under the control of PGK promoter. TRE promoter controls the expression of 
Ptch1, the level of which can be tuned by Doxycycline (Dox, Clontech, #631311). Clones with basal leaky 
expression of PTCH1 from the TRE promoter sufficient to suppress the pathway autoactivation were 
selected.  
• PTCH1-SynFB receivers (Figs. 4A, S13): In Ptch1-/- receivers, ectopic expression of PTCH1 was restored 
under the control of TRE promoter (32, 33). Clones with basal leaky expression of PTCH1 from the TRE 
promoter sufficient to suppress the pathway autoactivation were selected. Tet-3G level is controlled by 
the SHH pathway activity using the same GBS promoter that drives the Citrine reporter expression. Dox 
concentration controls the amount of PTCH1 expression for a given level of Tet-3G, and thus the 
feedback strength.  
• PTCH1-ΔLoop2-SynFB (Figs. 4E, S14): Dox-tunable synthetic feedback circuit was integrated into the 
wild-type receivers. Clones with complete absence of basal leaky expression of Ptch1-ΔLoop2 was 
selected.   
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Recombinant proteins and chemicals  
Recombinant mouse Sonic Hedgehog (rmSHHN) N-terminus (R&D, #464-SH-025) was dissolved in 1x Dulbecco 
PBS with 0.1% BSA. SMO activator Purmorphamine (Cayman Chemical, #10009634) and cell cycle inhibitor 
Roscovitine (Selleckchem, #S1153) were dissolved in DMSO.  
 
Reconstitution of morphogen gradient in vitro 
All gradient formation experiments were performed in 24-well tissue culture-treated µ-Plate (ibidi, #82406). 
Radial gradients were set up by mixing senders and receivers at a 1:1000 ratio, and thus individual senders were 
randomly distributed and spatially separated. 600,0000 cells were plated per well to force contact inhibition and 
cellular quiescence, which is required for NIH3T3 cells to become responsive to SHH stimulation. Linear 
gradients were set up using PDMS culture inserts (ibidi, #80209). 100,000 senders were seeded in a single 
rectangular space for 4-6 hrs. In situation where the sending strength of senders needs to be tuned, senders 
were mixed with wild-type NIH 3T3 cells at various ratios. Wild-type cells do not express any HH ligands. Once 
the senders adhere to the plate, inserts were removed and 600,000 receivers were plated in the same well. All 
gradients were set up the night before, and cells were induced at corresponding 4-OHT and/or Dox 
concentrations the next morning to initiate morphogen production and gradient formation. All cells were grown 
in DMEM media containing 10% serum throughout the course of gradient formation, and media was replaced 
every 12-24 hrs.  
 
Time-lapse fluorescence microscopy 
All time-lapse images were acquired on an inverted Olympus IX81 fluorescence microscope with Zero Drift 
Control (ZDC), an ASI 2000XY automated stage, iKon-M CCD camera (Andor, Belfast, NIR), and a 20x dry 
objective (0.7NA). Fluorophores were excited with an X-Cite XLED1 light source (Lumen Dynamics). Cells were 
kept in a custom-made environmental chamber enclosing the microscope, with humidified 5% CO2 flow at 37°C. 
Microscope and image acquisition were controlled by Metamorph software (Molecular Devices). Imaging usually 
started 2-3 hrs upon ligand stimulation or sender induction. Images were taken every 30 min, typically for 48–72 
hrs. For radial gradients, senders were chosen randomly during the setup stage based on the following pre-
established criteria: single senders are well separated from each other and away from the well edges by at least 
300 µm. Senders that remained as single cells without proliferation or death during the entire period were used 
for data analysis. The fraction of senders that stayed undivided and alive varies between 30 - 60%, depending on 
the initial cell density, cellular states and environmental conditions. Therefore, 20-30 individual senders were 
usually recorded for each experimental condition. For linear gradients, only the sender-receiver interface along 
the outer edge of the ibidi well were used for all experiments. The length of the interface typically allows 
selection of 7 fields of view without overlapping between adjacent fields, and avoiding regions where senders 
invaded receiver fields or non-straight sender-receiver interfaces. Generally, data from all fields of view were 
used for further analysis unless the sender-receiver interface shifted significantly over time due to uneven local 
cell densities and/or cell migration, which usually counts <3% of all data.  
 
Although the reconstituted system is three-dimensional (Fig. S2E), diffusive processes operate along each 
dimension independently. The widefield microscopy used for imaging signaling gradients effectively measures a 
2D projection of the 3D cell layer. This allows us to focus on transport in the x-y plane, which is the most 
relevant for these spatial patterning processes 
 
Quantitative analysis of linear SHH signaling gradients 
All image analysis was performed using customized Matlab program.  
• Automatic boundary detection: Senders were labeled with nuclear-localized mTurquoise2. Each pixel in 
the image (T(x,y,t)) was identified as mTurquoise positive (1) or negative (0) based on a fixed threshold 
above background. Sender density in space (T_mean(x,t)) was calculated by summing up the total 
mTurquoise pixel values along each column, orthogonal to the direction of the ligand diffusion. An 
average sender density profile was calculated by taking the temporal mean at all x positions 
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(T_mean2(x)), and fit to a Hill-like function a × bn / (bn + xn), with n ≥ 5. The position at which T_mean2(x) 
= 0.2a was defined as the boundary location.  
• Image normalization: To quantify the SHH signaling gradient in space and time, two normalization 
procedures were applied: (1) Background subtraction: media auto-fluorescence and camera background 
were imaged in media-only wells (F_back(x,y)) and subtracted from the raw data (F_raw(x,y,t)); (2) Field 
flattening: to assess the uniformity of illumination within the field of view in the Citrine and mCherry 
channels, wells containing FITC and Alexa Fluor 647 dyes in the media were imaged (F_standard(x,y)).  
All raw data were normalized:  
F(x,y,t) = (F_raw(x,y,t) - F_back(x,y)) / (F_standard (x,y) - F_back(x,y)) 
• Quantification of temporally integrated signaling activity in time and space: Signaling gradient in space 
measured by Citrine fluorescence intensity was calculated by the mean of all pixel values along each 
column, orthogonal to the direction of ligand diffusion. A smoothing procedure was then applied, both 
spatially and temporally. The transcriptional activity of the Citrine reporter comprises two components: 
(1) basal promoter activity due to the basal leaky activity of 8xGBS-miniCMV, which is GLI-, and thus SHH 
pathway-, independent; (2) SHH signal-induced activity, which is GLI-, and thus SHH pathway-, 
dependent. Because the GLI-dependent activity is what counts for the signaling gradient, we subtracted 
the Citrine signal due to the basal activity, which was deduced from the cells outside the gradient, at 
each corresponding timepoint.  
• Calculation of instantaneous signaling activity: The Citrine fluorescence reporter is fused to Histone 
H2B, which concentrates and stabilizes Citrine in the nuclei. The rate of Citrine fluorescent protein 
accumulation follows ∂Citrine/∂t = α - γ·Citrine, in which α is the production rate of Citrine and γ is its 
degradation rate constant. Because H2B-Citrine is very stable and cell proliferation is minimal under the 
high-confluency condition, γ is close to 0. As a result, ∂Citrine/∂t approximately equals α. α is controlled 
by the transcriptional activity of GLI, which is a direct readout of the SHH pathway signaling activity. 
Therefore, total Citrine represents temporally integrated signal activity, and its time derivative 
represents instantaneous signaling activity (Figs. 2C, 4C, S1-4).  
• Quantification of gradient properties, e.g. amplitude, lengthscale and time to reach steady state (τ): 
Amplitude and lengthscale were calculated based on total Citrine, which represents temporally 
integrated signaling activity (Figs. 2E, 4D-E, S4). Amplitude is defined as the Citrine intensity closest to 
the boundary. Lengthscale is defined as the distance over which the gradient drops to 1/e of its 
amplitude. Calculation of the time to reach steady state (τ) is based on the spatio-temporal dynamics of 
instantaneous signaling activity. The signaling activity is generally stabilized at all positions with 
unavoidable fluctuations after 30 hrs (Fig. 2C). Therefore, at any position, its mean signaling activity 
between 30 hr and the end of the movie approximates its steady state signaling activity (Fig. S4C). 𝜏 is 
defined as the earliest timepoint at which the signal intensity at the 50% decay length (the position at 
which the signal is 50% of the gradient amplitude) first reaches 90% of its steady-state value.   
 
Quantitative analysis of radial SHH signaling gradients 
The same image normalization procedure used in linear gradient analysis was applied to radial gradients. Single 
senders separated from each other by at least 300 µm were manually identified, and a single pixel was chosen 
as the center of the gradient. Concentric rings with single-pixel increment in the radius (r) were drawn around 
the gradient center (Fig. 1D, schematic). Mean fluorescence intensity per pixel within each annulus was 
calculated (F_mean(r,t)) and smoothed. F_mean(r, t) always exhibits nonmonotonic behavior: increasing and 
then decreasing with respect to r (space). This is because a single sender usually takes up an area of 10 x 10 
pixels in the middle of the gradient, and the actual gradient does not start at r=0. Therefore, we re-defined the 
gradient boundary as the position at which F_mean(r) is at its maximum value at the last timepoint. The rest of 
the data analysis used similar procedures as the linear gradient.  
 
Testing the route of ligand movement 
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To distinguish between two potential mechanisms of gradient formation (bulk diffusion through media vs. 
movement within the cell layer), we performed the following experiments:  
(I) Rocker experiment: Radial gradients were set up in 24-well plates in duplicate, with one plate on a still shelf 
and the other on a rocker (Boekel Scientific, Rocker II Model 260350). Rocker was rocking at the frequency of ~1 
Hz. Both plates were incubated in the same tissue culture incubator with appropriate temperature, humidity 
and CO2 control. Gradients were imaged and quantified at 48 hrs after 4-OHT induction.  
(II) Gap experiment: A 0.15 mm thick coverglass (VWR #48380068) was cut into two pieces with a 1:8 ratio of 
surface area and coated with Hamster fibronectin (Oxford Biomedical, #CH30) at a concentration of 5 µg/ml 
overnight. Senders were plated on the smaller piece and receivers on the larger piece. Once the cells were 
confluent, the two pieces of the same coverglass were placed in a single well of a 6-well plate and aligned such 
that the two pieces are in direct contact with each other (‘contact mode’), or with a gap of approximately 30 µm 
in between (‘gap mode’). In the contact mode, senders and receivers form a continuous monolayer culture. In 
the gap mode, senders and receivers cannot cross the gap to reach each other, neither there is a continuous 
extracellular matrix between the two cell populations. To prevent the coverglass from moving, the outer corners 
of the coverglass were fixed onto the bottom of the plate with agarose. Gradients were imaged at 48 hrs after 4-
OHT induction, on the EVOS FL Auto Cell Imaging System (ThermoFisher, #AMF4300) and a 10x objective.  
 
We noticed that a fraction of secreted ligands could escape from the monolayer cell into the culture media. 
However, such ‘free’ ligands in the media get mixed quickly in the entire well due to diffusion and convection. To 
keep the SHH concentration in the media below the threshold required for receiver activation, we kept the 
sender-receiver ratio as low as possible, the media volume as high as possible, and frequently changed the 
media (every 12 hrs). Frequent media change did not prevent gradient formation, further suggesting that the 
ligand in the media is not responsible for gradient formation.  
 
Estimation of the speed of signaling gradient formation  
Using the spatio-temporal dynamics of the signaling gradient activity (Fig. S2A), the speed of signaling gradient 
formation was estimated based on the Mean Squared Displacement (msd). By plotting the instantaneous 
signaling activity ∂Citrine(x,t)/∂t as a function of space (x), the msd (< x(t)2 >) at different timepoints (t) can be 
calculated:  
 < x(t)2 > = ∑ ((∂Citrine(x,t)/∂t) × x2 ) / ∑ (∂Citrine(x,t)/∂t) 
Deff can be estimated by taking linear regression of msd vs. time with a delay ∆t:  
< x(t)2 > = 2 × Deff × (t - ∆t) 
There are two points worth being noticed: (1) The linear regression is based on the assumption that time delay 
∆t is independent of the ligand concentration, but rather an inherent kinetic feature of the downstream signal 
transduction and transcriptional activation by GLI proteins. This assumption is supported by the time-lapse 
movies of receiver response dynamics with bath treatment of rmSHHN, in which the length of time delay does 
not appear to depend on the ligand concentration (figs. S3D, 13C); (2) The estimated Deff does not directly 
measure ligand diffusion, but rather the rate of signaling activity spreading in the cell layer. The value of Deff 
depends on several factors, including the ligand diffusion rate, the level of ligand and receptor, and the 
input/output function of SHH signal processing. Nevertheless, it offers an order-of-magnitude estimation about 
the speed of gradient formation, comparable to those measured in vivo for HH and other morphogens (32-34).  
 
Analysis of signaling activity and cell movement at the single-cell level 
In order to separate out individual nuclei while maintaining cellular responsiveness to SHH stimulation, we 
diluted signaling reporter-containing receiver cells with ‘dark’ wild-type NIH3T3 cells at 1:50 ratio. 150,000 cells 
in total were plated per well in tissue culture-treated 96-well µ-plate (ibidi, #89626). Cells were allowed to 
adhere overnight. rmSHHN or Purmorphamine were added to the media at 0 hr, and time-lapse movies were 
recorded under the same condition as the gradient movies. Individual nuclei were segmented, tracked and 
quantified for total Citrine fluorescence using customized programs (35). Promoter activity was calculated by 
taking the time-derivative of total Citrine (Fig. S1C). The spatial displacement of each cell relative to its position 
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at time 0 was calculated along the direction of gradient formation (x-axis in Fig. S2B). The squared displacement 
versus time is biphasic, with faster cell movement during the first 12 hrs and slower movement later. This 
behavior was quantified with a piecewise linear regression. The speed of cell movement is estimated by the 
slope of the regression (Fig. S2B-C). In both phases, the speed of cell movement is less than 10% of the speed of 
signaling gradient formation, suggesting cell movement plays an insignificant role in gradient formation. Similar 
results were obtained when the cell movement was analyzed along the y-axis, orthogonal to the direction of 
gradient formation (data not shown).  
 
Analysis of signaling dynamics at the population level with bath SHH treatment  
150,000 signaling reporter-containing receiver cells were plated per well in tissue culture-treated 96-well µ-plate 
(ibidi, #89626). Cells were allowed to adhere overnight. rmSHHN or Purmorphamine were added to the media at 
0 hr, and time-lapse movies were recorded under the same condition as the gradient movies. Similar 
normalization and quantification procedures used for the analysis of 1D gradients were applied to the data 
without tracking individual cells (Figs. S3D, S13C).  
 
Flow cytometry 
Samples for flow cytometry analysis were harvested using 0.05% Trypsin (Life Technologies), resuspended in 1x 
HBSS (Hank’s Balanced Salt Solution, Life Technologies) with 2.5 mg/ml BSA (Sigma, A4503), and filtered through 
40 µm strainers (BD Falcon) to remove aggregates. Fluorescence intensity was analyzed on a MACSQuant VYB 
flow cytometer (Miltenyi Biotec, Bergisch Gladbach, Germany). Data were analyzed with a custom Matlab 
program (EasyFlow, available upon request)(35).  
  
Quantitative RT-PCR 
We used quantitative RT-PCR to compare the synthetic reporter expression with endogenous SHH pathway 
target expression. Wild-type NIH3T3 cells containing the GBS-H2B-Citrine reporter were treated with different 
concentrations of rmSHHN for 24 hrs and lysed. Standard RNA extraction protocols with on-column DNase I 
digestion (Qiagen, #79254) using RNeasy mini kits (Qiagen, #74106) were performed. The concentration of 
extracted RNA was analyzed with NanoDrop and 500 ng RNA was used for a standard 20 μl iScript (Bio-Rad) 
reverse transcription reaction. 0.5 µl of the resulting cDNA was used for a 10 µl qPCR reaction (iQ SYBR Green 
Supermix, Bio-Rad, #1708880) on a CFX96 Real-Time Thermal Cycler (Bio-Rad). Each reaction had ≥2 technical 
replicates, with mouse Tbp as housekeeping control. The calculated ΔΔCq values (log2 fold change) for each 
gene (Gli1, Ptch1, and Citrine) across all rmSHHN concentrations were normalized between 0-1. Relative fold 
change of endogenous targets was plotted against relative fold change of Citrine (Fig. S1D). Primer sequences 
are provided in Table S4.  
    
RNA-seq and data analysis 
Wild-type NIH3T3 cells were grown to 100% confluency before vehicle control or 20 nM rmSHHN treatment in 
regular culture media. Total mRNA was purified after 48 hrs. Library was constructed according to standard 
Illumina protocols. Sequencing was performed on a HiSeq 2500 sequencer. Two biological samples for each 
condition were pooled together for sequencing. Data analysis was performed with a local instance of Galaxy 
(36), aligned to mm10 mouse reference genome. A standard analysis pipeline included Tophat, Cufflinks and 
Cuffdiff (37). 
 
 
Materials and Methods - Modeling 
Simulations 
Framework 
In order to closely tie experiment and modeling, we designed our models to approximate experimental 
conditions. The open loop system (Eqs. C.1-8) (17) and closed-loop PTCH feedback system (Eqs. D.1-5)(17) are 
each described by a set of five coupled, nonlinear partial differential equations, with the SHH ligand being the 
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only mobile species; other closed-loop systems (IC, EC, and uncoupled feedback) are modeled according to the 
same framework.   
 
We modeled gradient formation in one dimension across a receiver field 1000 µm wide by discretizing space 
into a 1000-element vector, with each element representing a virtual “cell” of width 1 µm. HH enters the 
receiver field at a constant flux 𝛼HH from the left-hand side. At the right-hand side, the system has an open (i.e., 
absorptive) boundary condition, mimicking the experimental setup, in which the receiver field stretches across 
several millimeters before reaching the side wall of the well.  Diffusion was modeled as hops between adjacent 
elements, turning the five coupled partial differential equations into a set of 1000*5 = 5000 coupled ordinary 
differential equations. Simulations of these coupled ODEs were performed in MATLAB (R0216a) using the 
ode15s solver.   
 
Simulations proceed in three steps: (1) pre-equilibration, (2) gradient simulation, and (3) gradient 
characterization. The same framework was used for more complex models incorporating full-length GLI, GLIA, 
GLI2 and GLI3, and/or adaptive behavior via GLI downregulation (supplementary text sections E-G).  
 
Pre-equilibration 
We assume that the concentrations of HH pathway components (P, C, R, and where appropriate, I and E) are at 
steady-state prior to initiation of HH production in the senders. This steady state is uniform in space and 
corresponds to the solution of the differential equations with H = 0 everywhere (note that this yields C = 0 
everywhere). For each simulation, we computed the steady-state solution analytically or by simulating the 
system forward in time until a steady state is reached. A system is deemed to be at steady state at time ti if, over 
the subsequent 4.5 hr, none of the species except for S (which accumulates continuously) changes by more than 
0.1% (Eq. H.5). After pre-equilibration, S is reset to zero.  
 
Gradient simulation 
The pre-equilibrated system constitutes the initial conditions for gradient simulation. At time t = 0, inward flux 
of SHH was turned on and the simulation was run forward in time, recording the concentration of each species 
every 30 min. Simulations presented in Fig. 2 and Figs. S5-6 were run for a fixed duration of 48 hr, the same 
length as the corresponding experiments. In these figures, we present results for S, the integrated signal, as this 
is what is measured experimentally. For simulations in Fig. 3 and Figs. S7-11, we analyzed the instantaneous 
signal ∂S/∂t in order to focus on the steady-state properties of the gradients. This choice is based on the fact 
that ∂S/∂t, but not S, is invariant to the length of the simulation and the dynamics of approach to steady state. 
Here, we defined steady-state stringently (Eq. H.5): a system is deemed to be at steady state at time ti if, over 
the subsequent 4.5 hr, none of the species except for S (which accumulates continuously) changes by more than 
0.1% (Eq. H.5).  Note that the measure “time to each steady state (τ)” is defined differently (Eq. H.6) to facilitate 
experimental measurement. τ is the earliest timepoint at which signaling activity at 𝜆50 [the distance, after the 
system has stabilized (Eq. H.5), at which the instantaneous signaling activity is 50% of its maximum] first reaches 
90% of its final value. We examined whether the decay lengthscale cutoff (50%, 37%, etc.) affects the 
conclusions about model performance and found that, except for cutoffs near 100%, PTCH feedback always 
produces the fastest τ (or ties for fastest with another architecture). 
 
Gradient Characterization 
After completion of each simulation, we computed metrics to characterize the signaling gradients 
(supplementary text section H).  Lengthscale (𝜆) is defined as the distance over which the gradient drops to 1/e 
of its highest value (Eqs. H.1-2). Amplitude (A) is defined as the signal intensity at the first “cell” (Eqs. H3-4).  The 
time to reach steady state (𝜏) is the earliest timepoint at which the signal intensity at the 50% decay length (the 
position at which the signal is 50% of the gradient amplitude) first reaches 90% of its steady-state value (Eq. 
H.6).   
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The sensitivity 𝜎%,'((of a metric y to 𝛼HH is defined as the log change in the metric divided by the log change in 𝛼HH (Eq. H.7). Practically, sensitivity was computed by calculating y at a particular value of 𝛼HH and at twice that 
value of 𝛼HH, with all other parameters held constant; with such a two-fold increase in 𝛼HH, the sensitivity 
reduces simply to the fractional change in the metric itself. 
 
Gradient shape was quantified with a shape factor 𝜃, defined as the length of the second third of the gradient 
(i.e., the distance over which ∂S/∂t decreases from ⅔ to ⅓ of the gradient amplitude) divided by the length of 
the first third of the gradient at steady state (Fig. 3E, Eq. H.8). Because lengths are quantized (taking on only 
integer values in microns), the 𝜃 versus 𝛼P curve is inherent choppy. To emphasize the underlying trend, we 
smoothed the curves in 3E using lowess smoothing with a window of 0.25. 
 
Parameter fitting 
Open loop fitting 
Parameters for the GLIR-only, GLIA+GLIR, and GLI2+GLI3 models were determined by bounded least-squares 
fitting (figs. S5B-D, S6B-C, and data not shown) to open loop experimental data. Parameter bounds (figs. S5D 
and S6C) were chosen based on prior experimental measurements or computational models (38-43). Fitting 
proceeded in two steps. First, the parameters describing the cell-autonomous species — i.e., P, C, R, and S for 
the GLIR-only model — as well as the interaction of P with H (Eqs. C.1-5, E.1-4, F.1-4) were determined by a 
global fit to the rmSHHN dose titration data (Fig. S1B) using the lsqnonlin function, with residuals weighted 
by the standard deviation of each datapoint (Figs. S5B, S6B). Fits were initialized 10-15 times with parameter 
guesses randomly and uniformly distributed in log space between the lower and upper bounds (Figs. S5D, S6C). 
We chose the parameter set resulting in the lowest weighted sum of squared residuals. Next, we fitted the 
spatial model (Eqs. C.6-8) to the observed gradient formation dynamics in the open loop system for four 
different 𝛼HH, all at 1x 𝛼PTC (Figs. S5C, S6B).  In this spatial fit, we fixed the parameters determined from the 0D fit 
and floated the newly-introduced parameters – D, 𝛾H, and 𝛼HH, as well as a multiplicative factor m relating the 
0D and 1D data amplitudes. Fits were run 10-15 times with parameter guesses randomly and uniformly 
distributed in log space between the lower and upper bounds. We chose the parameter set resulting in the 
lowest weighted sum of squared residuals. The first-order degradation term for H (Eq. C.6) was included to 
encapsulate constitutive degradation of H as well as loss to the media. Notably, 𝛾H << kon*P at the lowest value 
of P at steady state, implying that H depletion occurs predominantly through binding to P. 
 
Determination of feedback strengths 
The PTCH feedback strength 𝛽 was calculated to match the experimentally-observed 7-fold upregulation of 
PTCH production (reported by mCherry promoter activity) in receivers located at the sender-receiver boundary 
for relative 𝛼HH = 1.0. Given the other system parameters, a feedback strength 𝛽 = 36 in the GLIR-only model 
yields an approximately seven-fold increase in PTCH production at relative 𝛼HH = 1.0. Feedback strengths for the 
IC and EC models (𝛽I = 4.7 and 𝛽E = 12) in Fig. 3 were chosen to produce the same amplitude or lengthscale, 
respectively, as the PTCH model at relative 𝛼HH = 0.0625; note that because the IC and EC models each have only 
one tunable parameter, it is not possible to match both the amplitude and lengthscale to the values obtained by 
PTCH feedback. Those values of 𝛽I and 𝛽 were used for the uncoupled model in Fig 3.  Feedback strengths used 
in other figures are noted in the figure. 
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Supplementary Text 
 
A. Dependence of HH pathway activation on the receptor states: Free-Receptor Model vs. Ratio Model 
 
How HH pathway activity depends on states of the PTCH receptor has been debated in previously published 
studies. Taipale et al. suggested that free PTCH catalytically suppresses pathway activity (‘Free-Receptor Model’) 
(44), whereas Casali et al. proposed that signal activity depends on the ratio between ligand-bound and free 
PTCH (‘Ratio Model’) (45). We analyzed the two opposing models mathematically and compared them with our 
experimental observations. Our results support the Free-Receptor Model. The details of the calculation are 
included in this section.  
 
We constructed the models to match the conditions of the experiments with which we will compare them – 
specifically, bath treatment of open loop receivers with recombinant mouse SHH (Fig. S2C). We assume that 
ligand (H) and receptor (P) bind reversibly to form a complex (C) with a dissociation constant Kd.  𝐻 + 𝑃	 0123 𝐶  
Because H is in a large volume of media, the concentration of H stays constant despite its consumption by 
receivers. The dynamics of P and C are 𝑑𝑃𝑑𝑡 = 𝛼8 − 𝛾8𝑃 − 𝑘;<𝐻𝑃 + 𝑘;==𝐶 (A.1) 𝑑𝐶𝑑𝑡 = 𝑘;<𝐻𝑃 − 𝑘;==𝐶 − 𝛾>𝐶 (A.2) 
where the production rate of P is αP, the rate constant for the degradation of P is 𝛾P, and the rate constant for 
the degradation of C is 𝛾c. Solving for the steady state of Eqs. A.1-2 results in  𝛼8 − 𝛾8𝑃 − 𝛾>𝐶 = 0. (A.3) 
Assuming the binding and unbinding between H and P quickly reaches equilibrium, then by definition  𝐻𝑃𝐶 = 𝐾A. (A.4) 
From Eqs. A.3-4, free PTCH is  
 𝑃 = 𝛼8𝐾A𝛾8𝐾A + 𝛾>𝐻 (A.5) 
 
and the ratio between ligand-bound PTCH (C) and free PTCH (P) is 𝐶𝑃 = 𝐻𝐾A. (A.6) 
In the Free-Receptor Model, because PTCH negatively regulates the intracellular signal (S), we model S as 𝑆 = 𝐴 𝐾8<𝐾8< + 𝑃<			 (A.7) 
in which A is a scaling factor representing the maximum signal activity, KP is the concentration of P at which 
signal is half maximal, and n is the Hill coefficient. With Eqs. A.5 and A.7, the relationship between S and H in a 
bath treatment at steady state can be derived as  𝑆 = 𝐴 (𝛾8𝐾A + 𝛾>𝐻)<(𝛾8𝐾A + 𝛾>𝐻)< + G𝛼8𝐾A𝐾8 H<. (A.8) 
 
In the Ratio Model, we assume that the intracellular signal S depends on the ratio C/P, 
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𝑆 = 𝐴 G𝐶𝑃H<𝐾>< + G𝐶𝑃H< (A.9) 
where KC is the ratio of C/P at which signal is half maximal, and n is the Hill coefficient. With Eqs. A.6 and A.9, the 
relationship between S and H in a bath treatment at steady state can be calculated as  𝑆 = 𝐴 𝐻<𝐻< + (𝐾>𝐾A)<. (A.10) 
Comparing Eqs. A.8 and A.10, we see that the two models make different predictions about the relationship 
between S and H. The Free-Receptor Model predicts that the dose response curve of S vs. H depends on PTCH 
production rate (αP), while the Ratio Model predicts that the dose response curve does not depend on αP. Our 
experimental results (Fig. S3C) show that the dose response curve depends on αP, consistent with the results of 
Taipale et al. (44), and thus support the Free-Receptor Model.  
 
 
B. Ratiometric dependence of signaling gradient features on HH and PTCH production rates: a toy model  
 
We observed experimentally that both the amplitude and lengthscale of SHH signaling gradients in open loop 
receivers depend ratiometrically on the ligand and receptor production rates (Figs. 2E-F, S4D, S5F). In this 
section, we use a toy model to show that the "double-negative" logic of the core HH signaling pathway (Fig. 1B) 
is sufficient to generate the ratiometric behavior, under two assumptions: (1) the first-order degradation of free 
ligand (L) is much larger than degradation through receptor-mediated internalization (an assumption needed to 
obtain analytical results); and (2) the ligand concentration near the source (L0) is much higher than the ligand-
receptor dissociation constant (Kd), which is necessary for the formation of long-range gradients, as the majority 
of receptors near the boundary must be bound to ligand in order to prevent free receptor from retarding 
mobility of the ligand. The "double-negative" logic of the HH pathway in which ligand binding to the receptor 
PTCH relieves PTCH’s inhibitory effect on intracellular signaling is in contrast to the more prevalent "double-
positive" pathway architecture associated with morphogen pathways such as BMP and FGF, in which ligands 
activate receptors by forming ligand-receptor complexes, which in turn activate the intracellular signal. Under 
the same assumptions, in a double-positive toy model, signaling gradient amplitude depends only on the 
receptor production rate, while lengthscale depends on the product of ligand and receptor production rates. 
The details of this analysis are described below.  
 
The key difference between the “double-negative” vs “double-positive” pathways is the dependence of signaling 
activity on the abundance of free or ligand-bound receptors, respectively. Therefore, we first estimated the 
spatial profile of free receptor (R) and ligand-receptor complex (C) at steady state. Under the assumption that 
the distribution of L is unaffected by receptor binding, L(x) follows a stereotypical exponential decay profile in 
space (x) at steady state (46): 𝐿(𝑥) = 𝐿K𝑒MNOP  (B.1) 
with amplitude 		𝐿K = 𝑗KR𝐷𝛾T  (B.2) 
 
and lengthscale 𝜆T = R𝐷/𝛾T , (B.3) 
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where D is the ligand diffusion coefficient, j0 is the ligand flux at the left boundary and γL is the first order ligand 
degradation rate constant. In this approximation, cells passively sense the local ligand concentration through 
ligand (L)-receptor (R) binding that results in formation of a ligand-receptor complex (C) with a dissociation 
constant Kd so that   𝐿(𝑥) + 𝑅(𝑥) 0123 𝐶(𝑥).  
We assume that ligand-receptor binding and unbinding are sufficiently fast that complex formation is at 
equilibrium, and that C and R degrade with the same rate constant (γR).	 	 If	 R	 is produced at rate αR, and 
degraded at rate γR, the total level of receptor per cell R0 is 𝑅K = 𝛼\𝛾\ , (B.4) 
and the distributions of free receptor R and complex C at steady state are   𝑅(𝑥) = 𝑅K 𝐾A𝐾A + 𝐿(𝑥) (B.5) 
𝐶(𝑥) = 𝑅K 𝐿(𝑥)𝐾A + 𝐿(𝑥). (B.6) 
In the "double-negative" model, signal S(x) inversely depends on the level of free receptor R(x) 𝑆(𝑥) = 𝐾𝐾 + 𝑅(𝑥) (B.7) 
where K is the concentration of R at which the signal reaches half maximum. Prior to initiation of gradient 
formation, signaling in the receivers is negligible, i.e., S(0) ≈ 0, which requires R0 >> K. Without loss of generality, 
we assume that the Hill coefficient equals 1. The amplitude of the signal gradient is defined as the signal in the 
cell closest to the source. Based on Eqs. B.1, B.4 and B.6, with the assumption of L0 >> Kd at x = 0, then  𝑆(0) = 𝐾𝐾 + 𝑅K𝐾A𝐿K . (B.8) 
Signal gradient decay length λS is defined as  𝑆(𝜆]) = 𝑆(0)𝑒 . (B.9) 
With Eqs. B.1, B.2, B.3, B.5 and B.7, and the assumption of L0 >> Kd and R0 >> K, we obtain 𝑒MO^OP ≈ 𝐾A𝑒𝐾A + (𝑒 − 1)𝐾 𝐿K𝑅K	  
and thus,  
𝜆] ≈ 𝜆T ln c𝑒𝐾A + (𝑒 − 1)𝐾 𝐿K𝑅K𝐾A	 d.	 (B.10) 
Based on Eqs. B.2 and B.4, the ratio of total receptor and ligand concentrations at x=0 follows 𝑅K𝐿K ∝ 𝛼\𝛼T . (B.11) 
Because λL is independent of αL by assumption (Eq. B.3) and Kd is a constant, we find that amplitude 𝑆(0) ∝𝛼T/𝛼\  and lengthscale 𝜆] ∝ 𝛼T/𝛼\ both depend on the ratio of ligand to receptor production rates. 
 
In the "double-positive" model, signal S(x) depends on the ligand-bound receptor C(x) as 
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𝑆(𝑥) = 𝐶(𝑥)𝐾 + 𝐶(𝑥). (B.12) 
K is the concentration of C at which signal is half-maximal. Without loss of generality, we assume that the Hill 
coefficient equals 1.  The amplitude of the signal gradient can be calculated based on Eqs. B.1, B.6 and B.12, at x 
= 0 as 𝑆(0) = 𝐿K𝑅K𝐿K𝑅K + 𝐾(𝐿K + 𝐾A)	.  
Assuming that L0 >> Kd, the signal gradient amplitude can be approximated as 𝑆(0) = 𝑅K𝐾 + 𝑅K (B.13) 
and signaling gradient decay length λS, defined in Eq. B.9 and with Eqs. B.1-2, B.5 and B.12, can be approximated 
as 
 
 
 
To fairly compare this result to that for the "double-negative" pathway, we further assume that 𝑅K ≫ 𝐾, 
obtaining 𝜆] ≈ 𝜆T ln h(𝑒 − 1)𝐿K𝑅K𝐾𝐾A	 i.	 (B.14) 
Given Eq. B.11, the results in Eqs. B.13-14 show that in the "double-positive" pathway, signaling gradient 
amplitude primarily depends on the receptor production rate only, and decay length depends on the product of 
ligand and receptor production rates. Notably, the assumption of L0 >> Kd causes the signal to be saturated with 
respect to L0, such that changes in L0 cannot be sensed. In summary, the “double-negative” logic of the HH 
pathway is sufficient to generate the ratiometric behavior, and this behavior is unique to the “double-negative” 
pathway architecture.    
 
 
C. GLIR-only open loop model of HH spatio-temporal dynamics 
 
C.1.  Cell-autonomous HH signaling model    
In the HH pathway, in the absence of ligand, PTCH actively suppresses Smoothened, leading to the preferential 
processing of full-length GLI proteins into its transcriptional repressor form, GLIR. Ligand binding inactivates 
PTCH, relieving PTCH’s inhibition of Smoothened.  Activated Smoothened biases the processing of full-length GLI 
into its transcriptional activator form, GLIA. Because GLIA and GLIR share the same DNA-binding domain, they 
bind to the same binding sites (GBS) to influence transcription.  
 
Because we are interested in the input-output relationship describing the dependence of gene expression 
(which we refer to as “signaling activity”) on ligand, we sought a simple model describing this relationship.  We 
found that we could capture the temporal dynamics of signaling activity in response to bath application of ligand 
(Fig. S5B) with a model that includes only the receptor PTCH, the PTCH-HH complex, the repressor GLIR, and 
reporter gene expression (Fig. S5A). In this model, free PTCH promotes production of GLIR.  When PTCH binds to 
HH, GLIR production ceases, and GLIR levels fall as GLIR is degraded. As GLIR levels fall below the repression 
threshold KR, gene expression increases. The time needed for GLIR levels to fall before gene expression 
substantially increases creates the time delay observed in the “0D” bath application experiments.   
 
𝜆] ≈ 𝜆Tln	 h(𝑒 − 1)𝐿K(𝑅K + 𝐾))𝐾𝐾A	 i	.  
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The signaling intermediate R is included to produce the stereotypical time delay consistently observed in our 
experiments (Figs. S3D, S13C); a model in which P directly represses S production can recapitulate the steady-
state dose response curve but not the time delay (results not shown). Using GLIR dilution to create a time delay 
is consistent with experimental work suggesting that levels of repressive GLI protein could control the dynamics 
of pathway activation (47).  
 
We find that a more complex model explicitly describing full-length GLI and both GLIA and GLIR (Fig. S6A) 
produces similar results as the GLIR-only model (Fig. S6).  To focus on the role of feedback rather than the 
details of signal transduction, we use the simpler, GLIR-only model (Fig. S5A) throughout the main text and 
figures. 
 
The cell-autonomous (“0D”) GLIR-only model (Fig. S5A) includes four dynamical variables: free receptor PTCH 
(P), HH-PTCH complex (C), GLIR repressor (R), and the signaling reporter (S).  Free HH (H) is assumed to be 
constant, as HH is applied in a large bath of media that should create a large reservoir of ligand.  We made the 
following assumptions: 
(1) P promotes production of R, which inhibits signaling.  H binds to P to create complex C; this depletes P, 
which in turn results in reduced production of R. R levels fall as R is degraded, resulting in de-repression 
of signaling.  
(2) The signaling-controlled promoter (S) has a GLI-independent basal activity (αGBS,0) and GLI-dependent 
activity (αGBS * φR), with αGBS being the maximum GLI-regulated activity and φR being the degree of 
activation ranging from 0 to 1. φR is negatively controlled by GLIR. Specifically, φR is given by 𝜑\ 	= 𝐾\<k𝐾\<k + 𝑅<k. (C.1) 
 
With these assumptions, we obtain four ordinary differential equations describing the system 𝑑𝑃𝑑𝑡 = 𝛼8l> − 𝛾8𝑃 − 𝑘;<𝐻𝑃 + 𝑘;==𝐶 (C.2) 𝑑𝐶𝑑𝑡 = 𝑘;<𝐻𝑃 − 𝑘;==𝐶 − 𝛾>𝐶 (C.3) 𝑑𝑅𝑑𝑡 = 𝛼\ 𝑃<m𝐾8<m + 𝑃<m 			− 𝛾\𝑅 (C.4) 𝑑𝑆𝑑𝑡 = 𝛼no],K + 𝛼no]𝜑\. (C.5) 
 
Parameter values were determined by fitting this model to the 0D SHH dose response data (Fig. S5B, Table S2; 
see materials and methods). 
 
C.2. Addition of spatial dynamics to the model 
To model the spatial aspects of HH signaling, we started with the 0D system (Eqs. C.1-5), adding H as a 
dynamical variable and making all species a function of space as well as time. H is the only mobile species, 
diffusing with diffusion constant D, and its dynamics are described by  𝜕𝐻𝜕𝑡 = 𝐷 𝜕q𝐻𝜕𝑥q − 𝛾r𝐻 − 𝑘;<𝐻𝑃 + 𝑘;==𝐶. (C.6) 
 
To describe the quasi-1D gradients examined experimentally (Fig. 2B-C), we model the system in one spatial 
dimension. We thus obtain a system of five coupled partial differential equations (Eqs. C.2-6), with P, C, R and S 
modeled using the same equations as for the 0D system.  
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The boundary conditions are a fixed influx 𝛼rr of H at the sender-receiver boundary on the left-hand side and a 
zero-boundary condition at the other end of the receiver field: 𝜕𝐻𝜕𝑥sNtK = −𝛼rr/𝐷 (C.7) 𝐻(𝑥 = 𝐿) = 0 (C.8) 
where L is the width of the receiver domain.  The added parameters (D, γH, and αHH) were determined by fitting 
to the observed gradient formation dynamics in the open loop system for three different αHH, all at 1x αPTC (Fig. 
S5C, Table S2), with the cell-autonomous parameters from Eqs. C.1-5 fixed to those derived from the 0D fit.  We 
also included a multiplicative factor m relating the experimental 0D and 1D data signaling amplitudes. Because 
m is a phenomenological factor unrelated to our mechanistic model, we do not include it in these equations).  
See the “Parameter fitting” section in materials and methods. 	
 
 
D. Feedback models based on the GLIR-only model 
 
D.1.  PTCH feedback 
To simulate PTCH feedback, we introduce a GLIR-dependent production term for PTCH, while retaining its 
constitutive production term aPTC. The new term includes a maximum feedback-dependent production rate, 
β*aPTC, where β describes the maximum ratio of feedback-regulated production to constitutive production. 
Notably, β is the only new parameter introduced (boldfaced below) to describe feedback. Feedback-regulated 
production of P is inhibited by R according to same Hill-like function, 𝜑\(𝑅) (Eq. C.1), through which R inhibits 
production of S. The boundary conditions are the same as for the open loop model (Eqs. C.7-C.8).  𝜕𝐻𝜕𝑡 = 𝐷 𝜕q𝐻𝜕𝑥q − 𝛾r𝐻 − 𝑘;<𝐻𝑃 + 𝑘;==𝐶 (D.1) 𝜕𝑃𝜕𝑡 = 𝛼8l> + 𝜷𝛼8l>𝜑\ − 𝛾8𝑃 − 𝑘;<𝐻𝑃 + 𝑘;==𝐶 (D.2) 𝜕𝐶𝜕𝑡 = 𝑘;<𝐻𝑃 − 𝑘;==𝐶 − 𝛾>𝐶 (D.3) 𝜕𝑅𝜕𝑡 = 𝛼\ 𝑃<m𝐾8<m + 𝑃<m 	− 𝛾\𝑅	 (D.4) 𝜕𝑆𝜕𝑡 = 𝛼no],K + 𝛼no]𝜑\		 (D.5) 
 
D.2.  Models for alternative feedback architectures 
In Fig. 3 and Figs. S7-9, we compare PTCH feedback to alternative negative feedback architectures that omit 
certain molecular features of the PTCH feedback (Figs. 3A, S7A). Specifically, we examined the behavior of 
feedbacks lacking either extracellular activity (yielding purely intracellular feedback) or intracellular activity 
(yielding purely extracellular feedback), as well as feedback that implements both activities through distinct 
proteins (uncoupled feedback). Intracellular (IC) feedback operates through production of a species I that 
inhibits signaling intracellularly but does not bind to HH. Extracellular (EC) feedback operates through 
production of a species E that binds to HH but does not influence GLIR production. Uncoupled feedback features 
feedback-dependent production of both I and E. In all three models, PTCH is produced constitutively (as in the 
open loop model, Eqs. C.1 - C.6); PTCH production is required even in the IC, EC, and uncoupled models because 
PTCH is the only species capable of transducing extracellular HH concentration to intracellular signal activity. 
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To facilitate a direct and well-controlled comparison between these models, we assume that all feedback 
species have the same biochemical properties as PTCH (i.e., the same rate constants or parameters for 
production, degradation, binding and unbinding to HH, and regulation of GLIR) except for the specific activity it 
lacks by design (GLIR regulation for E, HH binding/unbinding for I). E and I are produced according to the same 
GLIR-inhibited, Hill-like function 𝜑\  (Eq. C.1) that controls P production, except that the scaling factors βE and βI 
need not be equal to β. 
 
The equations describing IC, EC, and uncoupled feedbacks are described below. The only free parameters – 
those not determined by the open loop fit – are βE and βI and are boldfaced. The boundary conditions are the 
same as for the open loop model (Eqs. C.7 – 8). 
 
 IC model 𝜕𝐻𝜕𝑡 = 𝐷 𝜕q𝐻𝜕𝑥q − 𝛾r𝐻 − 𝑘;<𝐻𝑃 + 𝑘;==𝐶 (D.6) 𝜕𝑃𝜕𝑡 = 𝛼8l> − 𝛾8𝑃 − 𝑘;<𝐻𝑃 + 𝑘;==𝐶 (D.7) 𝜕𝐶𝜕𝑡 = 𝑘;<𝐻𝑃 − 𝑘;==𝐶 − 𝛾>𝐶 (D.8) 𝜕𝐼𝜕𝑡 = 𝜷𝑰𝛼8l>𝜑\ − 𝛾8𝐼 (D.9) 𝜕𝑅𝜕𝑡 = 𝛼\ (𝑃 + 𝐼)<m𝐾8<m + (𝑃 + 𝐼)<m 	− 𝛾\𝑅	 (D.10) 𝜕𝑆𝜕𝑡 = 𝛼no],K + 𝛼no]𝜑\			 (D.11) 
 
EC model 𝜕𝐻𝜕𝑡 = 𝐷 𝜕q𝐻𝜕𝑥q − 𝛾r𝐻 − 𝑘;<𝐻(𝑃 + 𝐸) + 𝑘;==(𝐶 + 𝐶y) (D.12) 𝜕𝑃𝜕𝑡 = 𝛼8l> − 𝛾8𝑃 − 𝑘;<𝐻𝑃 + 𝑘;==𝐶	 (D.13) 𝜕𝐸𝜕𝑡 = 𝜷𝑬𝛼8l>𝜑\ − 𝛾8𝐸 − 𝑘;<𝐻𝐸 + 𝑘;==𝐶y  (D.14) 𝜕𝐶𝜕𝑡 = 𝑘;<𝐻𝑃 − 𝑘;==𝐶 − 𝛾>𝐶 (D.15) 𝜕𝐶y𝜕𝑡 = 𝑘;<𝐻𝐸 − 𝑘;==𝐶y − 𝛾>𝐶y  (D.16) 𝜕𝑅𝜕𝑡 = 𝛼\ 𝑃<m𝐾8<m + 𝑃<m 	− 𝛾\𝑅	 (D.17) 𝜕𝑆𝜕𝑡 = 𝛼no],K + 𝛼no]𝜑\		 (D.18) 
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Uncoupled IC+EC model 𝜕𝐻𝜕𝑡 = 𝐷 𝜕q𝐻𝜕𝑥q − 𝛾r𝐻 − 𝑘;<𝐻(𝑃 + 𝐸) + 𝑘;==(𝐶 + 𝐶y) (D.19) 𝜕𝑃𝜕𝑡 = 𝛼8l> − 𝛾8𝑃 − 𝑘;<𝐻𝑃 + 𝑘;==𝐶	 (D.20) 𝜕𝐸𝜕𝑡 = 𝜷𝑬𝛼8l>𝜑\ − 𝛾8𝐸 − 𝑘;<𝐻𝐸 + 𝑘;==𝐶y  (D.21) 𝜕𝐶𝜕𝑡 = 𝑘;<𝐻𝑃 − 𝑘;==𝐶 − 𝛾>𝐶 (D.22) 𝜕𝐶y𝜕𝑡 = 𝑘;<𝐻𝐸 − 𝑘;==𝐶y − 𝛾>𝐶y  (D.23) 𝜕𝐼𝜕𝑡 = 𝜷𝑰𝛼8l>𝜑\ − 𝛾8𝐼 (D.24) 𝜕𝑅𝜕𝑡 = 𝛼\ (𝑃 + 𝐼)<m𝐾8<m + (𝑃 + 𝐼)<m 	− 𝛾\𝑅	 (D.25) 𝜕𝑆𝜕𝑡 = 𝛼no],K + 𝛼no]𝜑\			 (D.26) 
 
Coupled, non-switching model 
We also considered a model in which feedback produces a protein Y with physically-linked (coupled) intracellular 
and extracellular functionalities, but in which intracellular function does not depend on ligand-binding state (Fig. 
S9D).   𝜕𝐻𝜕𝑡 = 𝐷 𝜕q𝐻𝜕𝑥q − 𝛾r𝐻 − 𝑘;<𝐻(𝑃 + 𝑌) + 𝑘;==(𝐶 + 𝐶|) (D.27) 𝜕𝑃𝜕𝑡 = 𝛼8l> − 𝛾8𝑃 − 𝑘;<𝐻𝑃 + 𝑘;==𝐶	 (D.28) 𝜕𝑌𝜕𝑡 = 𝜷𝒀𝛼8l>𝜑\ − 𝛾8𝑌 − 𝑘;<𝐻𝑌 + 𝑘;==𝐶|  (D.29) 𝜕𝐶𝜕𝑡 = 𝑘;<𝐻𝑃 − 𝑘;==𝐶 − 𝛾>𝐶 (D.30) 𝜕𝐶|𝜕𝑡 = 𝑘;<𝐻𝑌 − 𝑘;==𝐶| − 𝛾>𝐶|  (D.31) 𝜕𝑅𝜕𝑡 = 𝛼\ (𝑃 + 𝑌)<m𝐾8<m + (𝑃 + 𝑌)<m 	− 𝛾\𝑅	 (D.32) 𝜕𝑆𝜕𝑡 = 𝛼no],K + 𝛼no]𝜑\			 (D.33) 
 
E. GLIA + GLIR models to simulate open loop and various closed loop gradients  
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In most biological contexts, both GLI Repressor (R) and Activator (A) are produced from full-length GLI protein 
(F), and they compete for the same binding sites on DNA (4, 18, 39, 48).  Therefore, we expanded our GLIR-only 
model to include this additional detail, and then compared different feedback architectures in the context of 
this expanded model. In the new set of GLIA+GLIR models (Fig. S10A), we made the following assumptions: 
(1) Free PTCH (P) regulates the production rate of A, but not R. R is produced constitutively from F. 
(2) The signaling-controlled promoter (S) has a GLI-independent basal activity (αGBS,0) and GLI-dependent 
activity (αGBS * φAR), with αGBS being the maximum possible GLI-dependent activity and φAR being the 
degree of activation ranging from 0 to 1. φAR is controlled by two GLI binding sites for simplicity and 
consistency with published literature (18, 48). φAR is non-zero only when at least one of the sites is 
bound by GLIA and neither site is bound by GLIR. When both sites are bound by GLIA, the promoter 
produces twice as many transcripts as when only a single site is bound by GLIA. With these assumptions, 
we obtain 𝜑~\ = 𝐴q + 𝐾𝐴𝐴q + 2𝐾𝐴 + 2𝐾𝑅 + 2𝐴𝑅 + 𝑅q + 𝐾q  (E.1) 
(3) φAR controls the feedback loops, in lieu of φR. 
The GLIA+GLIR open loop model has 7 species: 
• H, P, C and S are modeled identically to the GLIR-only open loop model (Eqs. C.2-3, C.5-6), except that φR
is replaced with φAR (Eq. E.1). 
• The GLI species are simulated as follows:	𝜕𝐹𝜕𝑡 = 𝛼 − h𝑎~ 𝐾8<m𝐾8<m + 𝑃<m + 𝑎\ + 𝛾i𝐹 (E.2) 𝜕𝐴𝜕𝑡 = 𝑎~ 𝐾8<m𝐾8<m + 𝑃<m 𝐹 − 𝛾~𝐴		 (E.3) 𝜕𝑅𝜕𝑡 = 𝛼\𝐹	– 𝛾\𝑅		 (E.4) 
The GLIA+GLIR PTCH feedback model has 7 species: 
• H, P, C and S are modeled identically to the GLIR-only PTCH feedback model (Eqs. D.1-3, 5), except that
φR is replaced with φAR (Eq. E.1). 
• F, A, and R are modeled identically to the GLIA+GLIR open loop model (Eqs. E.2-4).
The GLIA+GLIR IC feedback model has 8 species: 
• H, P, C, I and S are identical to the GLIR-only IC feedback model (Eqs. D.6-9, 11), except that φR is
replaced with φAR (Eq. E.1). 
• F, A, and R are modeled identically to the GLIA+GLIR open loop model (Eqs. E.2-4).
The GLIA+GLIR EC feedback model has 9 species: 
• H, P, C, E, CE and S are identical to the GLIR-only EC feedback model (Eqs. D.12-16, 18), except that φR is
replaced with φAR (Eq. E.1). 
• F, A, and R are identical to the GLIA+GLIR open loop model (Eqs. E.2-4).
The GLIA+GLIR uncoupled feedback model has 10 species: 
• H, P, C, E, CE, I and S are identical to the GLIR-only uncoupled feedback model (Eqs. D.19-24, 26), except
that φR is replaced with φAR (Eq. E.1). 
• F, A, and R are identical to the GLIA+GLIR open loop model (Eqs. E.2-4).
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The open loop GLIA+GLIR model was fit to the experimental data using the same procedure as described for the 
GLIR-only model (Fig. S5B-D). This leaves the feedback strengths as the only tunable parameters. Simulations 
were performed using the same boundary conditions as in the GLIR-only model (Eqns. C.7-C.8). In the resulting 
model output, GLIA levels exceed GLIR levels proximal to the source, while GLIR levels exceed GLIA levels in 
distal regions, showing that in this parameter regime both forms of GLI play a role (Fig. S6D). This new set of 
models recapitulates the key conclusions of the GLIR-only models, including the ratiometric behavior of the 
open loop system and the robustness properties of different closed loop circuits (Figs. S6E, S10). These results 
demonstrate the separability of two levels of regulation: ligand-receptor interactions and intracellular signal 
transduction through GLI. The GLI-level regulation represents a module that processes input from unliganded 
PTCH (and, when present, I) and converts it to a target gene expression level. This module can be implemented 
in different ways (i.e., through GLIR alone or a combination of GLIA and GLIR) that produce the empirically-
observed dose response, and therefore preserves the effects of receptor-level feedback.  
 
 
F. GLI2+GLI3 models with upregulation of GLI2 (positive feedback) 
Unstimulated NIH3T3 cells predominantly express two GLI proteins, GLI2 and GLI3, at a similar mRNA level 
(Table S1). GLI2 acts mostly as a transcription activator, whereas GLI3 is both an activator and repressor. SHH 
pathway activation induces a 2-fold upregulation of GLI2, but not GLI3, and thus provides a positive feedback 
loop. To take these details into consideration, we further expanded the GLIA+GLIR models to explicitly represent 
full-length GLI2 (F2) and GLI3 (F3). In this new set of models, we made the following assumptions:  
(1) Both F2 and F3 are produced and degraded at the same basal rates (rate constants αF and γF, 
respectively). 
(2) Both F2 and F3 are processed into GLIA at the same maximum rate (αA) with the same dependence on 
free PTCH (P). The GLIAs derived from F2 or F3 are indistinguishable. 
(3) Both F2 and F3 are processed into GLIR at constant rates (αR2 and αR3) with αR2 being much smaller than 
αR3, pushing GLI2 to the activator form. The GLIRs derived from F2 or F3 are indistinguishable. 
(4) F2 production also depends on the signal, forming a positive feedback loop (βFL representing the strength 
of this feedback).   
 
The GLI2+GLI3 open loop model (Fig. S11A) with upregulation of GLI2 has 8 species: 
• H, P, C and S are identical to the GLIR-only open loop model (Eqs. C2-3, C5-6), except that φR is replaced 
with φAR (Eq. E.1).    
• The GLI species are simulated as follows. 	𝜕𝐹q𝜕𝑡 = 𝛼(1 + 𝛽T𝜑~\) − h𝑎~ 𝐾8<m𝐾8<m + 𝑃<m + 𝑎\q + 𝛾i𝐹q (F.1) 	𝜕𝐹𝜕𝑡 = 𝛼 − h𝑎~ 𝐾8<m𝐾8<m + 𝑃<m + 𝑎\ + 𝛾i𝐹 (F.2) 𝜕𝐴𝜕𝑡 = 𝑎~ 𝐾8<m𝐾8<m + 𝑃<m (𝐹q + 𝐹) − 𝛾~𝐴		 (F.3) 𝜕𝑅𝜕𝑡 = 𝛼\q𝐹q + 𝛼\𝐹	– 𝛾\𝑅		 (F.4) 
 
The GLI2+GLI3 PTCH feedback model with upregulation of GLI2 has 8 species: 
• H, P, C and S are identical to the GLIR-only PTCH feedback model (Eqs. D.1-3, D.5), except that φR is 
replaced with φAR (Eq. E.1).    
• F2, F3, A and R are modeled with Eqs. F.1-4.  
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The GLI2+GLI3 IC feedback model with upregulation of GLI2 has 9 species: 
• H, P, C and S are identical to the GLIR-only PTCH feedback model (Eqs. D.6-9, D.11), except that φR is
replaced with φAR (Eq. E.1). 
• F2, F3, A and R are modeled with Eqs. F.1-4.
The GLI2+GLI3 EC feedback model with upregulation of GLI2 has 10 species: 
• H, P, C, E, CE and S are identical to the GLIR-only EC feedback model (Eqs. D.12-16, D.18), except that φR
is replaced with φAR (Eq. E.1). 
• F2, F3, A and R are modeled with Eqs. F.1-4.
The GLI2+GLI3 uncoupled feedback model with upregulation of GLI2 has 11 species: 
• H, P, C, E, CE, I and S are identical to the GLIR-only uncoupled feedback model (Eqs. D.19-24, D.26),
except that φR is replaced with φAR (Eq. E.1). 
• F2, F3, A and R are modeled with Eqs. F.1-4.
G. A GLIA + GLIR model with downregulation of full-length GLIFL to create temporal adaptation 
In some developmental contexts, SHH signaling activity exhibits complete temporal adaptation, primarily due 
to the downregulation of full-length GLI production (18). To compare different feedback models under 
adaptive dynamics, we simulated all the models in Section E using the same parameters, except allowing the 
production rate of full-length GLI, αF, to be time-dependent (Fig. S12A-B). Computationally, αF(t) is a piece-wise 
linear function, with the transition timepoints (tdownreg = 30 h and 2.5*tdownreg = 75 h) chosen to match the 
observed signaling dynamics in mouse neural tubes (10). 
𝛼(𝑡) = ⎩⎪⎨
⎪⎧ 𝛼																																			𝑤ℎ𝑒𝑛	𝑡 ≤ 𝑡A;<𝛼2.5𝑡A;< − 𝑡 1.5𝑡A;< 				𝑤ℎ𝑒𝑛	𝑡A;< ≤ 𝑡 ≤ 2.5𝑡A;<0																																										𝑤ℎ𝑒𝑛	𝑡 > 2.5𝑡A;<  (G.1) 
All models were run for 96 hours. Complete adaptation was observed after 80 hrs. Because the steady state 
activity is zero for all models and positions, we analyzed the gradient amplitude, lengthscale and shape of S (the 
integrated signaling activity) at 96 hrs (Fig. S12D). 
H. Modeling methods and metrics 
For Fig. 2 and figs. S5-6 and S12, the lengthscale l is defined in terms of the integrated signal S(t,x).  tend is the 
last timepoint of the simulation. 𝜆 ≡ 𝑚𝑎𝑥 𝑥		𝑆(𝑡<A, 𝑥) ≥  ∗ 𝑆(𝑡<A, 1)) (H.1) 
For Fig. 3 and figs. S7-11, the lengthscale l is defined in terms of the instantaneous signal at steady state,  ](¡¢£1,N) ¡ 	, where tend is the last timepoint of the simulation, which runs until the system is at steady state 
(defined in Eq. H.5). 𝜆 ≡ 𝑚𝑎𝑥 𝑥		 ](¡¢£1,N) ¡ ≥  ∗  ](¡¢£1,) ¡ ) (H.2) 
For figs. S5-6 and 12, the amplitude A is defined in terms of the background-subtracted, integrated signal at 
steady state S(tend, x), 𝐴 ≡ 	𝑆(𝑡<A, 1) − 	𝑆(𝑡<A , 1000). (H.3) 
For Fig. 3 and figs. S7-11, the amplitude A is defined in terms of the background-subtracted, instantaneous signal 
at steady-state,  ](¡¢£1,N) ¡ 	, 
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𝐴 ≡ 𝜕𝑆(𝑡<A, 1)𝜕𝑡 −	𝜕𝑆(𝑡<A, 1000)𝜕𝑡 . (H.4) 
 
For the purposes of determining whether the system as a whole has reached steady state in a simulation, the 
steady state is defined as the first timepoint ti at which, for all species G (except S) and for all x, 
 ¤𝐺(𝑡 + 𝛿, 𝑥) − 𝐺(𝑡, 𝑥)𝐺(𝑡, 𝑥) ¤ < 10M	for	0 < 𝛿 ≤ 	4.5	ℎ (H.5) 
 
The time t for a quantity G (e.g., 𝜕𝑆 𝜕𝑡⁄ ) to reach steady state at x50 (where x50 is the distance at which G equals 
50% of its own steady-state maximum) is defined as 
 𝜏 ≡ 𝑚𝑖𝑛 ­𝑡	s	𝑎𝑏𝑠 °𝐺(𝑡, 𝑥±K) − 𝐺(𝑡<A, 𝑥±K)𝐺(𝑡<A, 𝑥±K) ² ≤ 0.10³. (H.6) 
 
The sensitivity 𝜎%,'((of a metric y to a change in aHH is defined for a 2-fold change in aHH: 
 𝜎%,'(( ≡	 𝜕 ln 𝑦𝜕 ln 𝛼rr ≈ (𝑦q∗'(( − 𝑦'(() 𝑦'((⁄(2 ∗ 𝛼rr −	𝛼rr) 𝛼rr⁄ = (𝑦q∗'(( − 𝑦'(()𝑦'((  (H.7) 
 
The shape factor q is defined as the length L2 of the second third of the gradient (i.e., the distance over which 
∂S/∂t decreases from ⅔ to ⅓ of the gradient amplitude) divided by the length L1 of the first third of the gradient 
at steady state, or 𝜃 = 𝐿q𝐿. (H.8) 
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Fig. S1. Characterization of the GBS reporter for SHH signaling activity. 
(A) The fluorescence reporter construct contains 8 tandem copies of GLI binding sequences (GBS), a minimal 
CMV promoter (miniCMV) and Citrine fluorescence protein fused to Histone H2B, all cloned into a PiggyBac 
vector (PB). (B) Dose response to rmSHHN (recombinant mouse SHH N-terminal peptide) treatment after 48 hrs 
in three representative clonal reporter cell lines (C4, C11 and C22, all in wild-type NIH3T3 background), 
measured by the population mean of Citrine intensity by flow cytometry. Different clones have similar dose 
response profiles (normalized curves, right), with variations in the absolute amplitude (left), potentially due to 
different copy numbers of the integrated reporter construct. min, basal level of Citrine without rmSHHN 
stimulation; max, maximum Citrine at saturating levels of rmSHHN. (C) Signaling dynamics in individual reporter 
cells by single-cell time-lapse imaging (mean ± s.e.m. for 50-100 cells each). H2B concentrates and stabilizes the 
Citrine fluorescent reporter in the nucleus, leading to a negligible Citrine degradation rate. Therefore, total 
Citrine represents temporally integrated signal, and its time derivative represents the promoter activity of the 
reporter, which is directly controlled by the instantaneous signaling activity in the cell (schematic, see Material 
and Methods “Calculation of instantaneous signaling activity” section for detailed explanation). SHH and 
Purmorphamine (Purm) activate the downstream pathway through different mechanisms, with Purm directly 
activating SMO downstream of the SHH receptor PTCH. Purm stimulation leads to a higher promoter activity, 
indicating that the saturating concentration of rmSHHN (50 nM) does not saturate the promoter of the reporter. 
(D) Citrine mRNA fold change linearly correlates with endogenous targets (Gli1 and Ptch1) of the SHH pathway in 
the C4 and C11 reporter cell lines. Reporter cells were stimulated with various rmSHHN concentrations for 48 
hrs and analyzed by qRT-PCR.  To represent Gli1 and Ptch1 fold changes on the same scale, results were 
normalized with the following calculation: (fold change - min)/(max-min), with min representing 0 nM rmSHHN 
and max representing the highest rmSHHN concentration. We chose C4 for all subsequent cell line engineering 
and gradient experiments.  
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Fig. S2. Quantifying the effects of cell migration, proliferation and overlap on gradient formation.  
(A) Estimation of the effective diffusion constant for signaling gradient formation (Deff). The spatiotemporal 
dynamics of signaling gradients were recorded by time-lapse imaging. The signaling activity, approximated by 
the rate of Citrine fluorescent reporter accumulation, which was calculated by taking the time derivative of total 
Citrine fluorescence. Deff is given by linearly regressing the mean squared displacement (msd) of signaling 
activity on time (see Materials and Methods for details). (B) Estimation of the speed of cell movement. Reporter 
cells (yellow) were diluted in an excess of ‘dark’ wild-type 3T3 cells, with a total cell density comparable to that 
in the spatial gradients. Cells were treated with rmSHHN, and Citrine fluorescence was monitored by time-lapse 
imaging. The positions of individual reporter cells were tracked, and the spatial displacement of each cell in a 
single dimension relative to its initial position was plotted as a function of time. Plots of the squared 
displacement versus time are biphasic, with faster cell movement during the first 12 hrs and slower movement 
later. This behavior was quantified with a piecewise linear regression. The speed of cell movement in both 
phases is less than 10% of the speed of gradient formation, suggesting that cell movement plays an insignificant 
role in gradient formation. Data (gray) show mean ± s.d. (n=303). (see Materials and Methods for more details). 
(C) SHH concentration does not have major effects on the speed of cell movement (top, n=288; bottom, n=338). 
(D) Inhibition of cell division with Roscovitine does not significantly affect gradient formation (left). Right: The 
rate of cell division depends on the initial plating density (white bars), and division can be completely inhibited 
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by 10 µM Roscovitine (mean ± s.d., student t-test). (E) Confocal microscopy shows that NIH3T3 cells cultured at 
confluency for 48 h form a multi-layered structure. (F) Defining the boundary between the sending and receiving 
fields. The sender density profile (cyan) was quantified by summing the number of mTurquoise2-positive pixels 
along each column, then fitting the sum to an inverse Hill function (magenta dotted line). Throughout the paper, 
the sender-receiver boundary is defined as the position at which the sender density drops to 20% of the 
maximum density (black solid line), to minimize the number of senders in the receiver zone. The region in which 
the sender density drops from 80% to 20% of the maximum density (red and black circles, respectively) 
represents a “transition zone”. The qualitative results in the paper do not depend on the exact value of the 
boundary threshold parameter, as Citrine levels change minimally within the transition zone.  
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Fig. S3. Construction and characterization of open loop receiver cells (as shown in Fig. 2A) 
(A) CRISPR-mediated deletion in both alleles of Ptch1 in the genome of SHH reporter cells (homozygous with the 
same mutation). Lower-case letters, intron sequences; uppercase letters, exon sequences; green highlights the 
deleted sequence. (B) Ptch1 homozygous deletion activates SHH signal reporter in the receiver cells in the 
absence of SHH. Flow cytometry 1 day after cells reached 100% confluency. (C) Flow cytometry analysis of open 
loop receiver cells (Fig. 2A) after 72 hrs of Dox and/or rmSHHN induction. Notice that basal leaky expression of 
PTCH1 from the TRE promoter (Dox 0 ng/ml) was sufficient to suppress auto-activation in Ptch1-/- cells. 
Additional PTCH1 expression can be tuned by titrating Dox concentration (ng/ml), as reported by the mCherry 
level (top). Increasing PTCH1 level reduces cell response to bath treatment with rmSHHN (bottom). (D) Time-
lapse imaging of the signal response dynamics under different rmSHHN concentrations (mean ± s.e.m., n=5). 
Top: Total Citrine represents temporally integrated signal; Bottom: the mean instantaneous signaling activity 
between 35-50 hr (blue circles) can be fit to a Hill-like dose titration curve (black line), with the fitted equation, 
coefficient values and their confidence intervals displayed.  
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Fig. S4. Characterizing the dependence of open loop signaling gradient features on 𝛼HH and 𝛼PTC (see also Fig. 
2).  
Gradients were reconstituted in the linear geometry with open loop receivers. (A) Senders and dark (unlabeled) 
wild-type NIH3T3 cells were mixed at different ratios to tune the ligand production rate (αHH); this sets the  
“relative αHH” value, defined as the ratio between the effective rate of ligand secretion at a given dilution to that 
at 100% senders. (B) Quantification of PTCH1 expression by measuring the total H2B-mCherry fluorescence (top) 
or the promoter activity of mCherry (bottom), mean ± s.d. (n=20). (C) Increasing αHH increases gradient 
amplitude (orange bar) and lengthscale (blue bar). Amplitude is defined as the signaling activity in the cell 
closest to the boundary. Lengthscale is measured by the distance where the signaling gradient drops below 1/e 
of its own amplitude. Gradients were quantified by either the time-integrated signal activity (top plots) or 
instantaneous signal activity (∂Citrine/∂t) at steady state (bottom plots). Representative gradient images are 
shown in Fig. 2E. (D) Gradient amplitude ratiometrically depends on the ligand and receptor production rates 
(𝛼HH and 𝛼PTC, respectively). Gradient lengthscale exhibits similar ratiometric behavior (Fig. 2E).  
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Fig. S5. A simple, GLIR-only model captures experimentally-observed open loop dynamics.  
(A) Open loop model (Eqs. C.1-8 in supplementary text). H, HH; P, free PTCH; S, signal; C, HH-PTCH complex; R, 
GLIR transcription factor. Free PTCH inhibits pathway activity by upregulating production of the repressor GLIR, 
which in turn inhibits signaling. When free PTCH is depleted by HH binding, new GLIR production ceases, and the 
existing pool of GLIR must decay below concentration KR in order to initiate signaling; the slow decay of GLIR 
levels after HH exposure explains the observed time delay between ligand exposure and the initiation of 
signaling (Fig. S1C). Arrows between H, P, and C indicate synthesis, degradation, binding and unbinding. The 
arrow from P to R indicates Hill-type activation of R synthesis with the indicated parameters [half-maximal 
activation level of PTCH (Kp), Hill coefficient (np), and maximum production rate (αr)]. Finally, the inhibitory arrow 
from R to S indicates a repressing Hill-type regulatory effect with indicated parameters [half-maximal inhibitory 
level of GLIR (KR), Hill coefficient (nR), and maximum GLIR-regulated promoter activity (αGBS)]. (B-D) Parameter 
values were determined by a two-step, least-squares fitting procedure. (B) First, a non-spatial, cell-autonomous 
version of the model (materials and methods, and Eqs. C.1-5) was globally fit to an SHH titration experiment in 
which rmSHHN was supplied at fixed concentrations via bath application (results from Fig. S3D). Fitting sought to 
minimize the weighted sum of squared residuals, which was calculated by summing the square of the difference 
between each datapoint and the corresponding model prediction, weighted by the standard deviation of the 
data at each point. (C) Next, the additional parameters needed for the spatial model — the diffusion constant D, 
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ligand production rate αHH, ligand first-order degradation rate γΗ, and a scaling factor relating the signaling 
intensity observed in the spatial datasets to those in the bath titration datasets — were determined by globally 
fitting the model to three spatiotemporal datasets (sender densities of 12.5%, 25%, and 50%) using open loop 
receivers with relative ɑPTC = 1.0.  In this fit, the cell-autonomous parameters obtained from the bath titration fit 
(fig S5B) were fixed.  As with the cell-autonomous fits, the residual between the data and model was weighted 
by the standard deviation of the data (see materials and methods). The cell-autonomous and spatial fits were 
run 10-15 times each, with the fits initialized with parameter guesses logarithmically distributed between 
reasonable bounds estimated from literature; the parameters resulting from the best fit (smallest weighted least 
squares) were chosen (see also Table S2). The upper and lower parameter bounds (gray triangles), parameter 
values obtained from each run (solid dots), and the parameters obtained from the best overall fit (red diamond) 
are shown in (D). (E) The model predicts that the amplitude of the signaling gradient depends ratiometrically on 
the ligand and receptor production rates (𝛼HH and 𝛼PTC, respectively), as observed experimentally (Fig. S4D).   
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Fig. S6. Explicit modeling of both GLIA and GLIR also captures experimentally-observed open loop dynamics 
and produces ratiometric behavior. 
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(A) Open loop GLIA+GLIR model (Section E in supplementary text). H, HH; P, free PTCH; S, signal; C, HH-PTCH 
complex; F, full-length GLI; R, GLIR transcription factor; A, GLIA transcription factor. Free PTCH inhibits pathway 
activity by repressing the production of GLIA. Arrows between H, P, and C indicate synthesis, degradation, 
binding and unbinding rates. Arrow from P to A indicates Hill-type inhibition of A synthesis with the indicated 
parameters. Finally, the inhibitory arrow from R to S and the activating arrow from A to S indicate transcriptional 
regulation by both A and R with indicated parameters. For simplicity, we assume that there are two GLI binding 
sites controlling production of S (18, 48). When both sites are bound by GLIA, the transcriptional output is 
twice that produced when one site is bound by GLIA and the other is unbound; when one or two GLIRs are bound, 
the promoter is fully repressed, except for a constitutive, leaky production rate of ɑGBS,0.  (B-C) Parameters in the 
model were determined using the same two-step, least-squares fitting procedure as in Fig. S5B-D. (D) The 
steady-state spatial distribution of GLIA and GLIR at relative 𝛼HH = 1.0 shows that GLIA predominates proximal to 
the source, while GLIR predominates at distal regions. (E) The amplitude and lengthscale of the signaling 
gradient depend ratiometrically on the ligand and receptor production rates (𝛼HH and 𝛼PTC, respectively).
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Fig. S7. Comparison of different negative feedback architectures in the GLIR-only model  
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(A) Cartoons describing the PTCH, intracellular (IC), extracellular (EC), and uncoupled negative feedback models. 
The only free parameters – those not determined by the open loop fit (Fig. S5) – are the feedback strengths 𝛽, 𝛽I 
and 𝛽E, describing the strengths of PTCH, IC, and EC feedbacks, respectively. These feedbacks are experimentally 
tunable by changing the concentration of Dox. (B) Detailed schematic of the feedback models (Eqs. D.1-26). The 
PTCH feedback model adds negative feedback to the open loop model in Fig. S5A. P now has two production 
terms: a constitutive term ɑPTC and an additional term negatively controlled by R (purple arrows). The feedback 
acts negatively overall, since signaling leads to upregulation of P, which in turn inhibits signaling in two ways 
(due to the bifunctionality of PTCH): first, by upregulating R production and, second, by reducing the 
extracellular ligand concentration H through sequestration and degradation. The strength of the feedback is set 
in the model by a parameter 𝛽, which is the ratio between the maximum rate of feedback-regulated P 
production and the rate of P produced constitutively. In Fig. 3, 𝛽 is set to 36 to match the experimentally- 
observed fold upregulation of P production (as reported by mCherry levels) in receivers immediately adjacent to 
a sender field consisting of 100% senders. IC and EC feedbacks are implemented by proteins I and E, 
respectively.  The biochemical parameters for I and E are identical to those of PTCH except that I cannot bind 
ligand and E does not regulate GLIR production. Uncoupled feedback includes both I and E, incorporated in the 
same manner as for IC and EC feedbacks. (C) Feedback models differ systematically, regardless of feedback 
strength. Each plot shows the lengthscale and amplitude of the gradient for each of the four feedback models at 
different feedback strengths (positions along curves), all at relative αHH = 0.125. The plots differ in the meaning 
of the marker size, which indicates lengthscale sensitivity (left), amplitude sensitivity (middle), or time to reach 
steady-state (right). Red arrowheads mark a feedback strength of 𝛽 = 36. Feedback strength differs four-fold 
between adjacent markers. EC feedback (green) enhances lengthscale robustness (i.e., lowers lengthscale 
sensitivity) at the cost of decreasing lengthscale and amplitude. IC feedback (orange) enhances amplitude 
robustness (i.e., lowers amplitude sensitivity) at the cost of decreasing amplitude and increasing lengthscale. 
When the IC and EC feedbacks are combined with the same feedback strengths in the uncoupled model (brown), 
the system behaves similarly to the IC feedback model across the entire range of feedback strength. In contrast, 
PTCH feedback (purple) increases both lengthscale robustness and amplitude robustness, with feedback 
strength affecting primarily amplitude (lengthscale is less sensitive to feedback strength). PTCH feedback also 
provides, along with EC feedback, the greatest acceleration of gradient formation. (D) The qualitative 
differences amongst the feedback architectures persist across sender strengths.  By tuning 𝛽I and 𝛽E, the 
amplitude of the IC model and the lengthscale of the EC model can be matched, at any particular value of αHH, to 
that of the PTCH model.  The uncoupled model adopts those fine-tuned values of 𝛽I and 𝛽E.  Given this tuning, 
the properties of the models diverge as αHH is changed. The PTCH feedback strength is fixed at 36 in all panels. 
The plots in the top row are identical to those in Fig. 3B, C and E.  
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Fig. S8. Steady-state distributions of ligand, feedback species, and signaling levels explain the origin of 
interference in the uncoupled model and the increase of lengthscale in the IC model.  
(A) Interference between IC and EC feedbacks in the uncoupled model. HH induces upregulation of both I and E. 
E levels become depleted due to binding to H, but I (orange solid line), which is not antagonized by H, simply 
accumulates. Accumulating levels of I dampen (magenta inhibitory arrow) production of E (green solid line), 
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preventing replenishment of E levels. In contrast, in the EC model, E production (dotted green line) is much 
stronger near the source, allowing replenishment of depleted E. All feedback strengths are identical to the ones 
used in Fig. 3. The marked difference between the E production rates in the uncoupled and EC models (solid and 
dotted green lines, respectively) — despite identical values of 𝛽E — is due to the presence of I in the uncoupled 
model. (B) Steady-state spatial distributions of signaling activity (left), ligand levels (center), and feedback 
species (right) for different feedback models. All plots use relative 𝛼HH = 1.0 and the same feedback strength (𝛽, 𝛽I or 𝛽E) used in Fig. 3. In the open loop (OL), PTCH feedback, and EC feedback models, perception roughly 
follows ligand concentration. By contrast, in the IC and uncoupled models, the perception profile shows a 
plateau relative to the ligand, suggesting plateau-like shapes in perception gradients could be indicative of 
intracellular negative feedback. (C) IC feedback preferentially inhibits signaling activity in the proximal region. In 
the open loop (OL) model, signaling activity is inversely dependent on the abundance of free PTCH (P, dashed 
magenta line); in the IC model, signaling activity is inversely dependent on the sum of P and I (P, solid magenta 
line; I, solid orange line; and I + P, solid cyan line). The level of inhibitory species at which signaling is half-
maximally downregulated is KP.  The ratio between the inhibitory species in the two models — I + P (cyan) in the 
IC mode versus P (dotted magenta line) in the OL model — is much greater proximal to the senders.  The greater 
level of inhibition in the proximal vs distal region (black arrows) means that signaling is disproportionally 
inhibited in the proximal region. This flattens the shape of the signaling gradient (plot of normalized signal 
perception in (B)) proximally. This plateauing, in turn, leads to increased lengthscale, as lengthscale is defined as 
the distance at which the signaling activity decreases to 1/e of its value in the most proximal cell. At the same 
time, a “threshold lengthscale”, defined as the distance at which a certain absolute level of signaling is reached, 
decreases due to the reduction in signaling activity everywhere.  
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Fig. S9. The uncoupled model underperforms PTCH feedback even when the component feedback strengths 
are fine-tuned. 
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(A) Dependence of steady-state lengthscale and amplitude on the two feedback strengths (𝛽I and 𝛽E) in the 
uncoupled feedback model at relative 𝛼HH = 0.25. Red circles denote values of 𝛽I and 𝛽E fine-tuned to produce a 
lengthscale and amplitude equal to that of PTCH feedback at 𝛽 = 36. (B) Comparison of steady-state signaling 
gradients produced by PTCH and uncoupled feedbacks, with the uncoupled feedback strengths (𝛽I and 𝛽E) 
individually fine-tuned, as shown in (A), to match the lengthscale and amplitude of PTCH feedback at different 
values of 𝛼HH (different shades of cyan). PTCH feedback strength 𝛽 was set at 36. Regardless of the fine-tuned 
values of 𝛽I and 𝛽E, the uncoupled model systematically diverges from the PTCH model. However, in some cases, 
fine-tuning allows the uncoupled model to reach steady state slightly faster than the PTCH feedback model. (C) 
The evolutionarily-conserved PTCH feedback outperforms alternative pathway architectures in enhancing the 
lengthscale robustness, shape robustness, and speed of formation of signaling gradient. Performance 
differences are systematically preserved across different feedback strengths and ligand production rates. 
Performance is measured relative to that of the open loop model, which has a value of 1 in each dimension. The 
PTCH feedback strength was fixed at 36 across different 𝛼HH values. The feedback strengths for other models 
were independently tuned at a given 𝛼HH so that the amplitude of the IC model, lengthscale of the EC model, and 
both the amplitude and lengthscale of the uncoupled model match the corresponding properties of the PTCH 
feedback model. The plot representing the matching point at 𝛼HH = 0.25 is identical to Fig. 4F. (D) Performance 
of the coupled, non-switching model.  In this model, a hypothetical receptor-like molecule Y physically couples 
intracellular and extracellular activities. Y acts like PTCH to bind HH, but both the ligand-free and ligand-bound 
states suppress the intracellular signal (cartoon on the left; compare to the cartoons in Fig S7A). The only free 
parameter is the feedback strengths 𝛽Y. (Right) Comparison of steady-state signaling gradients produced by 
PTCH feedback and coupled, non-switching feedback. The PTCH feedback strength 𝛽 was set at 36. The coupled, 
non-switching model is shown for a variety of feedback strengths 𝛽Y. Note that regardless of the value of 𝛽Y, the 
coupled, non-switching model underperforms the PTCH model in terms of amplitude robustness, lengthscale 
robustness, shape robustness, and time to reach steady state. 
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Fig. S10. PTCH Feedback outperforms other feedback designs in the GLIA+GLIR model.  
(A) Cartoons describing the open loop, PTCH, intracellular (IC), extracellular (EC), and uncoupled negative 
feedback models that incorporate full-length GLI (F), GLIA (A) and GLIR (R). The only free parameters – those not 
determined by the open loop fit (Fig. S6) – are the feedback strengths 𝛽, 𝛽I and 𝛽E, describing the strengths of 
PTCH, IC, and EC feedbacks, respectively. (Section E in supplementary text). These feedbacks are tunable 
experimentally by changing the concentration of Dox. (B) Steady-state gradient properties for different models. 
Left: length and amplitude as a function of 𝛼HH (marker size); middle: time to reach steady state (𝜏) for each 
model as a function of λ50 and 𝛼HH; right, gradient shape (𝜃) as a function of 𝛼HH. The definitions of λ50, 𝜏 and 𝜃 
are the same as in Fig. 3. The qualitative differences between different feedback models are preserved in the 
GLIA+GLIR model. PTCH feedback strength 𝛽 was set to 16 to match the experimentally-observed fold 
upregulation of P production (as reported via mCherry levels) in receivers immediately adjacent to a field of 
100% senders. The feedback strengths of the IC and EC models were fine-tuned (𝛽I=1.04 and 𝛽E=16) so that the 
amplitude or lengthscale, respectively, matches that of PTCH feedback at 𝛼HH = 0.0625. Those same feedback 
strengths were used for the uncoupled model.  
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Fig. S11. PTCH feedback outperforms other feedback designs in the GLI2+GLI3 model. 
(A) Cartoon of a model incorporating both GLI2 and GLI3 to explicitly simulate a moderate upregulation of GLI2 
expression upon signal activation. F2, full-length GLI2; F3, full-length GLI3; R, GLIR transcription factor; A, GLIA 
transcription factor. The rate of GLIR production from F2 (light gray arrow) is much smaller than the rate from F3 
(black arrow), making GLI2 primarily a transcription activator. The model does not distinguish the A or R 
produced by F2 versus F3. Free PTCH inhibits the pathway activity by repressing the production of A from both F2 
and F3. Arrows between H, P, and C indicate synthesis, degradation, binding and unbinding rates. The inhibitory 
arrow from R to S and the activating arrow from A to S indicate transcriptional regulation by both A and R, with 
the same functional form as in the GLIA+GLIR model. Finally, the signal controls the production of F2 — a 
positive feedback — at the strength of 𝛽FL (Section F in supplementary text). Parameters in the model were 
determined using the same two-step, least-squares fitting procedure as in Fig. S5B-D (Table S2). The fit value 
for 𝛽FL tends to produce less GLI2 compared to the experimentally measured 2-fold increase in the Gli2 mRNA 
level. To ensure that we are assessing the effects of non-trivial levels of GLI2 upregulation, we turned up 𝛽FL to 
2.4 for subsequent analysis. (B) Steady-state gradient properties for different models. Left: lengthscale and 
amplitude as a function of 𝛼HH (marker size); middle: time to reach steady state (𝜏) for each model as a function 
of λ50 and relative 𝛼HH; right, gradient shape (𝜃) as a function of relative 𝛼HH. The definitions of λ50, 𝜏 and 𝜃 are 
the same as in Fig. 3. The qualitative differences between different feedback models are preserved in the 
GLI2+GLI3 model. The PTCH feedback strength 𝛽 was set to 16 to match the experimentally-observed fold 
upregulation of P production (as reported via mCherry levels) in receivers immediately adjacent to a sender field 
consisting of 100% senders. The feedback strengths for the IC and EC models were fine tuned (𝛽I = 2.4 and 𝛽E = 
8) so that the amplitude or lengthscale, respectively, matches that of PTCH feedback at 𝛼HH = 0.0625. Those
same feedback strengths were used for the uncoupled model. Note that the addition of GLI2 feedback 
systematically slows the time to approach steady states, consistent with previous reports on the role of positive 
feedback (49, 50). This does not change the qualitative conclusions about the relative behaviors of different 
types of feedback.
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Fig. S12. PTCH feedback outperforms other feedback designs in the presence of temporal adaptation.  
(A) Temporal adaptation, which is weak or non-existent in our other models, was simulated by making the 
production rate of full-length GLI time-dependent (𝛼f(t)), with production decreasing over time. Otherwise, the 
model is identical to the GLIA+GLIR model described in Fig. S6. Feedback models incorporate the same time-
dependent production of full-length GLI. In vivo, temporal adaptation is a feature in some, but not all, SHH 
morphogenetic contexts. This variation in occurrence suggests that adaptation is not an intrinsic feature of the 
pathway but rather could result from mechanisms such as downregulation of SHH synthesis or downregulation 
of full-length GLI expression (18), with the latter explicitly modeled here. (B) 𝛼f(t) is a piecewise linear function 
that declines to zero between 30-75 hrs, to match the timing of adaptation previously reported in the mouse 
neural tube (10). (C) Temporal profiles of signaling activity (top row), GLIA abundance (middle row), and GLIR 
abundance (bottom row) in different models with temporal adaptation. Shades of blue represent the distance 
away from the source. Feedback strengths are identical to those in Fig. S10. (D) Performance of the different 
feedback models in the presence of adaptation. Left: because steady-state signaling activity is 0 in all models, we 
instead analyzed the temporally integrated signal (area under curve); middle: length and amplitude as a function 
of 𝛼HH (marker size); right, gradient shape (𝜃) as a function of 𝛼HH.   
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Fig. S13. Characterization of the PTCH1-SynFB receiver cell line (as shown in Fig. 4A). 
(A) Synthetic PTCH1 feedback reduces the overall signaling response to rmSHHN (bottom left). The amount of 
PTCH1, indicated by mCherry level (bottom right), depends on both SHH and Dox concentrations. No increase in 
mCherry was observed in the absence of Dox (black line) or SHH (0 nM rmSHHN data points). The Dox 
concentration controls the strength of the feedback, as indicated by the ratio between mCherry and Citrine 
(top). All data represent mean of population distributions obtained by flow cytometry after 72 hr of indicated 
treatment. (B) The feedback strength of PTCH1-SynFB can be tuned to be similar to, or even stronger than, the 
strength of PTCH feedback in wild-type (WT) NIH3T3 cells, quantified by qRT-PCR after 48 hrs of treatment. 
Notice that at the same rmSHHN concentration, WT cells had higher fold change in Ptch1 expression without 
serum than with 10% serum. However, to keep cells relatively healthy, all the gradient experiments were 
performed with 10% serum in the media. (C) Time-lapse imaging shows that mCherry dynamics follow the 
Citrine reporter dynamics under constant rmSHHN and Dox concentrations. rmSHHN and Dox were added to 
SynFB receivers at 0 hr, and dynamics were recorded by time-lapse imaging. Each time trace represents the 
population average under the given combination of rmSHHN and Dox concentrations. Dashed lines indicate the 
time when Citrine signal activity (top plots) becomes detectable. These results show that the feedback is not 
“leaky” and is activated shortly after signaling begins. Each trace averages over 10 fields of view. (D) PTCH1-
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SynFB reduces gradient sensitivity to variations in αHH experimentally. The effects depend on the strength of the 
feedback, controlled by Dox concentration. Top row, total Citrine representing temporally integrated signaling 
gradient (same data as Fig. 4D, without normalization); bottom row, total mCherry representing the amount of 
feedback. Gradients were reconstituted using the senders described in Fig. 1C induced with 100 nM 4-OHT, and 
imaged at 42.5 hr. (E) PTCH1 feedback improved amplitude (left panel) and lengthscale (middle panel) 
robustness to variations in ligand production rates, as well as accelerated the approach to steady state (right 
panel). The performance depends on the strength of PTCH1 feedback, and WT cells behaved similarly to PTCH1-
SynFB cells at intermediate feedback strength. Data shown as mean ± s.e.m. (n=10 each). (F) Quantification of 
gradient shape for different pathway architectures and feedback strengths. Both WT NIH3T3 cells (purple) and 
PTCH1-SynFB (magenta and red) improved the linearity of the gradient. Both open loop (black) and PTCH1-
ΔLoop2-SynFB (IC feedback at 75 ng/ml Dox, orange) displayed plateau-like gradient shapes at high 𝛼HH. Data 
shown as mean ± s.e.m. (n=10 each). 
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Fig. S14.  Characterization of open and closed loop PTCH1-ΔLoop2 receiver cells. 
(A) Design of the PTCH1-ΔLoop2 mutant. An extracellular loop was deleted to eliminate its interaction with HH 
(25). (B) PTCH1-ΔLoop2 or PTCH1 were integrated into wild-type receiver cells in the open loop configuration, 
with the expression level tuned by Dox concentrations, reported by the mCherry (mChr) level. (C) The open loop 
receiver cells show decreased signaling activity (Citrine) with increasing level of PTCH1 or PTCH1-ΔLoop 
(mCherry). Notice that at a given mCherry level, PTCH1-ΔLoop2 is more effective at suppressing intracellular 
signaling than PTCH1. This is because ligand binding inactivates PTCH1, but PTCH1-ΔLoop2 is unaffected by SHH. 
At the same protein production rate, a higher level of free PTCH1-ΔLoop2 protein will accumulate, leading to 
stronger suppression of intracellular signaling activity. Cells were treated with 50 nM rmSHHN at 0 hr and 
analyzed by flow cytometry at 48 hrs. (D) IC feedback enhances the robustness of gradient amplitude to 
variations in ligand production rates. Reconstituted linear gradients with PTCH1-ΔLoop2 closed loop receivers 
(same experiment as Fig. 4E). Feedback strength can be tuned with Dox from no feedback (0 ng/ml) to high 
feedback (75 ng/ml). Top row, total Citrine representing temporally integrated signaling gradient; bottom row, 
total mCherry representing the amount of feedback. Gradients were reconstituted using the senders 
constructed in Fig. 1C induced with 100 nM 4-OHT, and imaged at 42.5 hr.  
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Tables 
 
Table S1. The expression level of HH pathway components 
Category Gene Locus 
Untreated 
(FPKM) 
rmSHHN 
treated 
(FPKM) 
Fold change 
(rmSHHN/Untreate
d) 
Ligands SHH chr5:28456839-28719209 0 0 N/A 
Dhh chr15:98893026-98898540 0 0 N/A 
Ihh chr1:74945317-74951651 0.11 0 N/A 
Gli 
Transcription 
Factors & 
Signal 
Transduction 
Components 
Gli1 chr10:127323726-127341579 1.21 27.32 22.58 
Gli2 chr1:118834060-119053619 6.33 11.23 1.77 
Gli3 chr13:15463722-15730025 7.36 6.57 0.89 
Ptch2 chr4:117096355-117114831 0 0.21 N/A 
Ptch1 chr13:63511532-63565520 4.00 38.63 9.66 
Smo chr6:29735496-29761366 75.68 69.99 0.92 
Sufu chr19:46396917-46486660 16.13 16.36 1.01 
Kif7 chr7:79660195-79714186 4.33 4.65 1.07 
Cul3 chr1:80266817-80340430 63.99 58.24 0.91 
Spop chr11:95414082-95493410 71.98 74.07 1.03 
Co-receptors 
& other HH-
binding 
proteins 
Boc chr16:44485044-44558870 1.54 1.65 1.07 
Cdon chr9:35452075-35507652 22.81 32.15 1.41 
Gas1 chr13:60174404-60177535 475.98 385.43 0.81 
Lrp2 chr2:69424334-69586067 0.02 0 N/A 
Hhip chr8:79965850-80058008 0 0 N/A 
Hhat chr1:192512827-192771219 12.25 14.71 1.20 
Disp1 chr1:183086263-183221529 7.89 7.48 0.95 
Disp2 chr2:118779718-118795175 0.29 0.57 1.97 
Scube2 chr7:109798690-109865679 0.13 0.05 0.38 
Notum chr11:120653788-120660837 0 0 N/A 
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Table S2.  Parameters used in the computational models 
GLIR-only Model (Fig. 2-4, figs. S5 and 7-9, Eqs. C.1-6 and D.1-26) 
Parameter Description Units Fitted value 
αPTC Free PTCH Production rate nM min-1 0.024‡ 
γP Free PTCH degradation rate constant min-1 0.006‡ 
γC HH-PTCH degradation rate constant min-1 0.1539 
Kh HH-PTCH dissociation constant nM 2.2771 
koff HH-PTCH complex dissociation rate constant  min-1 0.3018 
KP Hill constant for PTCH control of GLIR production nM 0.5660 
nP Hill coefficient for PTCH control of GLIR production unitless 0.9 
αR GLIR production rate constant nM min-1 0.3908 
γR GLIR degradation rate constant min-1 0.002‡ 
KR Hill constant for GLIR control of signal production nM 8.5184 
nR Hill coefficient for GLIR control of signal production unitless 1.5735 
αGBS GLIR-dependent signal production rate constant a.u. min-1 5.6881*10-3 
αGBS,0 Basal (GLIR-independent) signal production rate constant a.u. min-1 9.8715*10-5 
D Free HH diffusion constant  μm2 min-1 58.3931 
αHH HH flux into receiver field at 100% sender strength nM min-1  0.5431 
γH Free HH degradation rate constant min-1 8.1346*10-4 
b PTCH feedback strength, as fold increase over αPTC unitless 36 
m Multiplicative factor relating the amplitude in 1D experiments to that in 0D experiments (1D divided by 0D) unitless 1.8657 
GLIA+GLIR Model (figs. S6, 10 and 12, supplementary text Section E and G) 
Parameter Description Units Fitted value 
αPTC Free PTCH Production rate nM min-1 0.024‡ 
γP Free PTCH degradation rate constant min-1 0.006‡ 
γC HH-PTCH degradation rate constant min-1 0.1488 
Kh HH-PTCH dissociation constant nM 2.5422 
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koff HH-PTCH complex dissociation rate constant  min-1 0.6983 
KP Hill constant for PTCH control of GLIR production nM 0.0050 
nP Hill coefficient for PTCH control of GLIR production unitless 1.0986 
αR Rate constant for GLIR production from full-length GLI nM min-1 0.0663 
γR GLIR degradation rate constant min-1 0.002‡ 
αA Rate constant for GLIA production from full-length GLI nM min-1 8.1436 
γA GLIA degradation rate constant min-1 0.02 
αF Full-length GLI production rate constant nM min-1 1.2609 
γF Full-length GLI degradation rate constant min-1 0.002‡ 
Kgli Hill constant for GLIA/R control of signal production nM 0.1001 
αGBS GLIR-dependent signal production rate constant a.u. min-1 0.0045 
αGBS,0 Basal (GLIR-independent) signal production rate constant a.u. min-1 1.6405*10-4 
D Free HH diffusion constant  μm2 min-1 32.3941 
αHH HH flux into receiver field at 100% sender strength nM min-1  0.4740 
γH Free HH degradation rate constant min-1 1.1593*10-4 
b  PTCH feedback strength, as fold increase over αPTC unitless 16 
m Multiplicative factor relating the amplitude in 1D experiments to that in 0D experiments (1D divided by 0D) unitless 1.7042 
GLI2+GLI3 Model (Fig. S11, supplementary text Section F) 
Parameter Description Units Fitted value 
αPTC Free PTCH Production rate nM min-1 0.024‡ 
γP Free PTCH degradation rate constant min-1 0.006‡ 
γC HH-PTCH degradation rate constant min-1 0.1067 
Kh HH-PTCH dissociation constant nM 1.8124 
koff HH-PTCH complex dissociation rate constant  min-1 0.9157 
KP Hill constant for PTCH control of GLIA production nM 0.0100 
nP Hill coefficient for PTCH control of GLIA production unitless 1.3007 
αF Full-length GLI2/3 production rate constant nM min-1 0.7610 
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γF Full-length GLI2/3 degradation rate constant min-1 0.002‡ 
αA Rate constant for GLIA production from full-length GLI2/3 nM min-1 1.9996 
αR2 Rate constant for GLIR production from full-length GLI2 nM min-1 0.00326 
αR3 Rate constant for GLIR production from full-length GLI3 nM min-1 0.0315 
γA GLIA degradation rate constant min-1 0.020 
γR GLIR degradation rate constant min-1 0.002‡ 
Kgli Hill constant for GLIA and GLIR control of signal production nM 0.1501 
αGBS GLIA/R-dependent signal production rate constant a.u. min-1 0.0022 
αGBS,0 Basal (GLI-independent) signal production rate constant a.u. min-1 1.3854*10-4 
D Free HH diffusion constant  μm2 min-1 52.3942 
αHH HH flux into receiver field at 100% sender strength nM min-1  0.4898 
γH Free HH degradation rate constant min-1 7.644*10-6 
b PTCH feedback strength, as fold increase over αPTC unitless 16 
m Multiplicative factor relating the amplitude in 1D experiments to that in 0D experiments (1D divided by 0D) unitless 2.5595 
bFL GLI2 feedback strength, as fold increase over αF unitless 2.3797 
  
‡ Fixed in the fit 
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Table S3. DNA constructs used in the study 
Construct Name Promoter Gene Refseq Antibiotics Role in this study 
Super PiggyBac 
Transposase 
Expression Vector $ 
CMV PiggyBac transposase N/A N/A To facilitate the 
integration of target 
vectors 
PB-PGK-ERT2-
GAL4-T2A-H2B-
mTurquoise2 
PGK ERT2-GAL4 N/A Blastomycin To generate 
inducible senders 
expressing mouse 
SHH 
H2B-mTurquoise2 
PB-UAS-SHH UAS Shh NM_009170 Hygromycin 
PB-EF1a-Tet3G EF1α Tet3G§ N/A Puromycin To control the 
expression of mouse 
PTCH1 
PB-GBS-miniCMV-
H2B-Citrine 
8xGBS-
miniCMV 
H2B-Citrine N/A Hygromycin Reporter for HH 
pathway activity 
PB-TRE3G-
miniCMV-Myc-
mPtch1-T2A-H2B-
mCherry 
TRE3g-
miniCMV § 
Myc-Ptch1 NM_008957 Blastomycin To control the 
expression of mouse 
PTCH1 
H2B-mCherry N/A 
PB-TRE3G-
miniCMV-Myc-
mPtch1-ΔLoop2-
T2A-H2B-mCherry 
TRE3g-
miniCMV § 
Myc-mPtch1-ΔLoop2 N/A Blastomycin To control the 
expression of 
mutant mouse 
PTCH1-ΔLoop2 H2B-mCherry N/A 
PB-GBS-miniCMV- 
Tet3G 
8xGBS-
miniCMV 
Tet3G § N/A Puromycin To control the 
expression Tet3G in 
the feedback circuit 
pX330-U6-
Chimeric_BB-CBh-
hSpCas9(51, 52)
Cbh hSpCas9 N/A N/A CRISPR backbone for 
knocking out Ptch1 
$ Directly purchased from System Biosciences (#PB200PA-1) 
§ Subcloned from the Tet-On® 3G Inducible Expression System (Clonetech, 631346)
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Table S4.  Nucleic Acid Oligo sequences used in the study 
Name Sequence Role in the study 
CRISPR03-
gRNA02F 
5’-CACCGCAGGGCGTGAGCGCTGTCA-3’ To generate CRISPR targeting mPtch1, 
forward strand 
CRISPR03-
gRNA02R 
5’-AAACtgacagcgctcacgccctgc-3’ To generate CRISPR targeting mPtch1, 
reverse strand 
mPtch1_F104 5’-CTCCTCATATTTGGGGCCTT-3’ qPCR primer for mouse Ptch1, forward 
mPtch1_R104 5’-AATTCTCGACTCACTCGTCCA-3’ qPCR primer for mouse Ptch1, reverse 
mGli1_F119 5’-GAGGTTGGGATGAAGAAGCA-3’ qPCR primer for mouse Gli1, forward 
mGli1_R119 5’-CTTGTGGTGGAGTCATTGGA-3’ qPCR primer for mouse Gli1, reverse 
mTbp_F109 5’-ACATCTCAGCAACCCACACA-3’ qPCR primer for mouse Tbp, forward 
mTbp_R109 5’-GTGAAGGGTACAAGGGGGTG-3’ qPCR primer for mouse Tbp, reverse 
Citrine_F96 5’-CACATGAAGCAGCACGACTT-3’ qPCR primer for Citrine, forward 
Citrine_R96 5’-GGTCTTGTAGTTGCCGTCGT-3’ qPCR primer for Citrine, reverse 
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Movies 
Movie 1: SHH signaling gradient formation in radial geometry with open loop receivers. 
The movie shows representative SHH signaling gradient formation in radial geometry. Senders were induced 
with 100 nM 4-OHT at 0 hr, and no Dox was added. mTurquoise2 labels the sender cell nuclei, and Citrine 
reports the signal activity. 
Movie 2: SHH signaling gradient formation in linear geometry with open loop receivers. 
The movie shows representative SHH signaling gradient formation in linear geometry. Senders were induced 
with 100 nM 4-OHT at 0 hr, and no Dox was added. mTurquoise2 labels the sender cell nuclei, and Citrine 
reports the signal activity. 
Movie 3-6: SHH signaling gradient formation in linear geometry with PTCH1-SynFB receivers. 
The same senders and receivers were used for Movie 3-6. PTCH1 feedback is off in Movie 3-4 and on in Movie 5-
6. Senders were induced with 100 nM 4-OHT at 0 hr for all movies, and receivers were induced with vehicle 
control or Dox at 0 hr. mTurquoise2 labels the sender cell nuclei, Citrine reports the signal activity, and mCherry 
reports the PTCH1 feedback level.  
Movie 3: SHH signaling gradient formation with PTCH1-SynFB receivers at relative αHH = 0.25 and 0 ng/ml Dox. 
(25% sender + 75% wild-type NIH3T3 cells in the sender region) 
Movie 4: SHH signaling gradient formation with PTCH1-SynFB receivers at relative αHH = 1.00 and 0 ng/ml Dox. 
(100% sender + 0% wild-type NIH3T3 cells in the sender region) 
Movie 5: SHH signaling gradient formation with PTCH1-SynFB receivers at relative αHH = 0.25 and 20 ng/ml Dox.  
(25% sender + 75% wild-type NIH3T3 cells in the sender region).  
Movie 6: SHH signaling gradient formation with PTCH1-SynFB receivers at relative αHH = 1.00 and 20 ng/ml Dox.  
(100% sender + 0% wild-type NIH3T3 cells in the sender region) 
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